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ABSTRACT OF THE DISSERTATION 
MATERNAL-FETAL ATTACHMENT AND HEALTH BEHAVIORS 
AMONG WOMEN WITH HIV/AIDS 
by 
Julieta P. Hernandez 
Florida International University, 2014 
Miami, Florida 
Professor David Cohen, Major Professor 
Background: Mothers with HIV often face personal and environmental risks for poor 
maternal health behaviors and infant neglect, even when HIV transmission to the infant was 
prevented. Maternal-fetal attachment (MFA), the pre-birth relationship of a woman with her 
fetus, may be the precursor to maternal caregiving. Using the strengths perspective in social 
work, which embeds MFA within a socio-ecological conceptual framework, it is hypothesized 
that high levels of maternal-fetal attachment may protect mothers and infants against poor 
maternal health behaviors. Objective: To assess whether MFA together with history of substance 
use, living marital status, planned pregnancy status, and timing of HIV diagnosis predict three 
desirable maternal health behaviors (pregnancy care, adherence to prenatal antiretroviral therapy–
ART, and infant’s screening clinic care) among pregnant women with HIV/AIDS. Method: 
Prospective observation and hypothesis-testing multivariate analyses. Over 17 consecutive 
months, all eligible English- or Spanish-speaking pregnant women with HIV ( n = 110) were 
approached in the principal obstetric and screening clinics in Miami-Dade County, Florida at ≥  
24 weeks’ gestation; 82 agreed to enroll. During three data collection periods from enrollment 
until 16 weeks after childbirth (range: 16 to 32 weeks), participants reported on socio-
demographic and predictor variables, MFA, and pregnancy care. Measures of adherence to ART 
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and infant care were extracted from medical records. Findings: Sociodemographic, pregnancy, 
and HIV disease characteristics in this sample suggest changes in the makeup of HIV-infected 
pregnant women parallel to the evolution of the HIV epidemic in the USA over the past two 
decades. The MFA model predicted maternal health behaviors for pregnancy care (R2 = .37), with 
MFA, marital living status, and planned pregnancy status independently contributing (β  = .50,  
β  = .28, β  = .23, respectively). It did not predict adherence to ART medication or infant care. 
Relevance: These findings provide the first focused evidence of the protective role of MFA 
against poor maternal health behaviors among pregnant women with HIV, in the presence of 
adverse life circumstances. Social desirability biases in some self-report measures may limit the 
findings. Suggestions are made for orienting future inquiry on maternal health behaviors during 
childbirth toward relationship and protection. 
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CHAPTER I: INTRODUCTION 
Research Problem 
Few studies have examined what facilitates desirable health behaviors among 
pregnant women with HIV, such as caring for oneself during pregnancy or caring for 
one’s infant after giving birth. Findings from these studies suggest that the developing 
emotional relationship between the pregnant woman and her fetus, called maternal-fetal 
attachment (MFA) in the present study, may motivate women to practice optimal 
maternal health behaviors (D’Auria et al., 2006; Mellins et al., 2008). This suggestion, 
however, has not been empirically tested, and the present study does so. 
Over the last decade, authors have discussed and researched disruptions in the 
caregiving role of HIV-infected mothers, and the impact of mothers’ HIV disease on the 
emotions and behavior of their school-aged children (Fair, 2006; Hough et al, 2003; 
Murphy et al., 2006; Murphy et al., 2011; Rotherum-Borus et al., 2001). In contrast, 
difficulties related to early infant caregiving among these mothers are less understood. 
The field of infant mental health offers conceptual tools to understand why early caring 
relationships and safe family environments before and after childbirth result in optimal 
socio-emotional development of infants exposed to HIV (Shonkoff & Phillips, 2000). 
The importance of maternal-fetal attachment, postulated as a pre-birth mother-infant 
relation, lies in its potential for promoting optimal maternal health behaviors during 
pregnancy and after childbirth, including the reduction of omissions in infant medical 
care.  
2 
 
The present study integrates findings from the recent literature on pregnant 
women with HIV/AIDS, child maltreatment, infant mental health, and pregnancy. From 
an ecological analytical framework (Bronfenbrenner, 1979) and a strengths-based 
approach to women living difficult circumstances (Saleebey, 1992, 2006), this study 
examines directly the link between maternal-fetal attachment and health behaviors among 
pregnant women with HIV. It posits that high levels of maternal-fetal attachment will be 
associated, in the period surrounding birth, with more desirable pregnancy-related, HIV-
related, and infant-related maternal health behaviors. In addition, maternal-fetal 
attachment together with history of illicit substance use, marital partner status, planned 
pregnancy status and HIV diagnosis before or during pregnancy, will predict these 
desirable maternal health behaviors. To test these hypotheses, data are gathered using a 
prospective observational study and linear relationships between the variables are 
estimated in regression equations.  
If HIV-infected women with a high level of attachment to their fetus are more 
likely to treat their chronic illness, nurture their pregnant body, and protect their infants 
from HIV infection exacerbated by non- or lesser adherence with prenatal antiretroviral 
therapy and from other adverse outcomes, then practitioners could explore the possibility 
of enhancement of  these mothers’ and children’s wellbeing by enhancing maternal-fetal 
attachment or addressing unresolved issues related to the development of this prenatal 
relationship.  
Significance of the Study 
Among the estimated 1.1 million persons living with HIV in the U.S. by the end 
of 2010, 280,000 (24%) were women; 60% Black, 19% Hispanic/Latina, and 18% White. 
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That year women accounted for 20% of new infections (The Kaiser Family Foundation, 
2013). For the first time since 2008, new HIV infection among women decreased 
significantly by 21%; however, Black and Hispanic/Latina women accounted for 64% 
and 15% of new infections, while representing only 13% and 16% of the US female 
population, respectively (The Kaiser Family Foundation, 2013). Moreover, HIV 
incidence rates are 20 (38.1 per 100,000) and 4 (8.0 per 100,000) times higher for Black 
and Hispanic/ Latina women, respectively, compared to White women (1.9 per 100,000; 
Kates et al., 2013).    
The effectiveness of currently used combined ART to achieve HIV suppression 
means that women with HIV are living longer and healthier lives (Kates et al., 2013). 
Moreover, prenatal ART is associated with a mother-to-child HIV transmission rate of 
less than 2% today, compared to 25% in untreated women (Thorne, 2005; Whitmore et 
al., 2011). The success in preventing mother to child transmission in the U.S. has 
undoubtedly strengthened HIV-infected women’s desire for childbearing and their 
perception of this disease as manageable and not precluding procreation (Lindau et al., 
2005). An increasing number of women are more likely to become pregnant, continue a 
pregnancy, or have multiple pregnancies after their HIV diagnosis than in previous years 
(Blair et al., 2004; Firth et al., 2012). Yet despite improved treatments, timely utilization 
of health care remains problematic among women diagnosed with HIV/AIDS; indeed, the 
continuum of care from diagnosis to viral suppression shows a dramatic “treatment 
cascade,” from 85% of the estimated 280,000 seropositive women receiving a diagnosis 
in 2010, to only 26% of them achieving viral suppression (Kates et al., 2013).  
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Approximately 76% of new HIV infections in women occur in the childbearing 
years, between the ages of 13 and 44; in recent surveys, over a third of women living 
with HIV/AIDS identified themselves as parents (39%) and/or caregivers (52%; Murphy 
et al., 2002; Kates et al., 2013). Whitmore et al. (2009) estimated that in 2006 the number 
of births to all women living with HIV in the U.S. was between 8,650 and 8,900. Even 
though less than 2% of infants are infected at birth in mothers who receive ART in the 
U.S., maternal adherence to ART regimens and related clinical services (i.e., adherence to 
clinic visits for HIV viral load measures), prenatal care visits, and follow-up pediatric 
visits for testing of the HIV-exposed infant vary across individuals.  
The variation in women’s ability to practice prescribed maternal health behaviors 
goes beyond individual awareness of HIV status and personal coping strategies to the 
diagnosis or disease, and relates to specific demographic, psychological and social 
characteristics (Firth et al., 2012; Riley et al., 2011). For example; U.S.-born HIV-
infected women living in Rhode Island tend to have two or less prenatal care visits, and 
higher likelihood of child protection agency involvement with their children, compared to 
those foreign-born. Conversely, women born outside the U.S. often experience language, 
educational and economic difficulties in obtaining prenatal care (Firth et al.). Firth et al.’s 
findings about the changing face of HIV during pregnancy in the U.S. alert health social 
workers to assess personal and contextual barriers and facilitators in adherence to existing 
protocols to prevent the transmission of HIV from mother to child. The present study 
explored whether variations in maternal-fetal attachment modified by history of pre-
pregnancy drug use, marital relationship status, planned pregnancy status and timing of 
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HIV diagnosis predict variations in HIV-, pregnancy-, or infant-related maternal health 
behaviors. 
Regardless of HIV status, timely and adequate prenatal care offers women the 
opportunity to reduce the risk of poor pregnancy outcomes such as low birth weight and 
pre-term birth, and to promote maternal health. Additionally, for pregnant women with 
HIV, prenatal care may help to prevent mother-to-child HIV transmission and to 
encourage their adherence to ART. Poor prenatal care highly compromises the health of 
the HIV-exposed unborn child. As a result, in child welfare laws in many states 
(Dubowitz, 2002; US Department of Health and Human Services, 2011, Wolf et al., 
2001), poor attendance to postnatal HIV screening infant care visits is considered a form 
of medical child neglect. In turn, medical child neglect is considered among the most 
common type of child maltreatment, according to conceptual definitions (English et al., 
2005).  
This study is significant for three reasons. First, adjusting the research lens on 
maternal health behavior in pregnancy from a deficit to a strengths-perspective (Saleebey, 
1992) may broaden explanations for facilitators of maternal health behaviors beyond the 
facilitators conventionally observable in medical settings, to include the under-recognized 
abilities of women manifested in maternal-fetal attachment. Second, by assessing prenatal 
and postnatal maternal health behaviors in relation to maternal-fetal attachment, this 
study may add to the knowledge on ecological models of resilience in pregnancy and 
birth. Third, this research may uncover uncharted opportunities to promote positive 
maternal health behaviors and prevent child maltreatment (i.e. infant medical neglect), 
which could alter these families’ life trajectories long before childhood or adolescence.  
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Overall, strengths-framed research (Saleebey, 1992) among HIV-infected 
pregnant women has been scarce yet appears necessary as the treatment-impacted course 
of HIV/AIDS no longer dooms a mother to very early death. The strengths perspective is 
used here within a larger socio-ecological conceptual framework of pregnancy, childbirth 
and early child development, where maternal-fetal attachment is embedded in a 
multilayered socio-economic milieu (Bronfenbrenner, 1979; Dunkel Schetter et al., 
2011). Based on the literature, personal, familial and socio-cultural conditions assessed in 
this study include the following self-reported variables: history of drug use, number of 
life births, partner cohabitation, planned or unplanned pregnancy, timing of HIV 
diagnosis, housing, educational level, income, and race/ethnicity. This study may 
contribute to a better conceptual definition of maternal resilience in pregnancy and birth; 
it may advance the design of interventions aiming to promote positive maternal health 
behaviors and prevent infant medical neglect by strengthening prenatal attachments 
among mothers and infants affected by HIV/AIDS.  
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CHAPTER II: LITERATURE REVIEW 
Maternal Health Behaviors among Pregnant Women with HIV/AIDS 
Coping with HIV/AIDS and pregnancy. Pregnant women living with HIV face 
the double task of coping with stressors associated to different stages of pregnancy, and 
HIV disease progression (Abatemarco et al., 2008; Ethier et al., 2002). Pregnancy may 
have varying effects on these women, relative to the timing of the HIV diagnosis and 
other factors in the life of each woman. Pregnancy may expose some to new stressors, 
while serving to “inoculate” others from the stressors; or the same woman may have 
mixed reactions at once or throughout the pregnancy (Gil & Loh, 2010; Jenkins & Coons, 
1996). For example, a woman living with HIV who becomes pregnant may feel 
discouraged by the added burden of reproductive health-related concerns or judgment 
from family and friends. She may delay seeking prenatal care. Or, she could 
optimistically embrace the pregnancy, appraising it as a positive life-affirming event that 
prompts her to adhere to her medication regimen in order to improve her health and 
protect her fetus (Ivanova et al., 2012; McIntosh & Roselli, 2012). On the one hand, for 
the women who acquired HIV at birth and grew up with this disease, pregnancy is only 
one more struggle in the lifelong set of personal, developmental, medical and social 
struggles to survive HIV/AIDS (Millery et al., 2012; Badell & Lindsay, 2012). On the 
other hand, a woman who receives the HIV diagnosis during pregnancy may react to the 
traumatic news with shock, anger and fear of dying. Simultaneously, the prospect of a 
new life may provide her with hope, optimism and motivation to live. The concerns to 
protect the unborn child from the threat of HIV may strengthen her determination to stay 
healthy and survive, or it may distract her from dealing with this devastating diagnosis 
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(Kelly et al., 2012). The wide range of reactions of the newly HIV diagnosed women in 
the context of pregnancy may include fear of dying, and concern for the welfare of the 
fetus, mixed with a renewed sense of self-worth and self-confidence in the maternal role. 
After learning about her HIV diagnosis, a woman may decrease or increase her adherence 
to antiretroviral medication, or may deteriorate or strengthen her emotional health, 
depending on her coping strategies (Njie-Carr et al., 2013). Regardless of timing of the 
HIV diagnosis, the positive reframing of the pregnancy, in the face of multiple stressors, 
may predict enhanced psychological health, and positive health among women living 
with HIV/AIDS (McIntosh & Roselli).  
Notwithstanding the sociocultural differences among cohorts of HIV-infected 
women around the world, international studies have observed similar findings on the 
diverse and evolving emotional or behavioral reactions of women who simultaneously 
face HIV and pregnancy, further helping to understand the coping behaviors of women 
diagnosed during pregnancy. Pereira and Canavarro (2012) found that pregnancy in the 
presence of HIV infection intensifies negative (e.g., fear, guilt, sadness) and positive 
(e.g., happiness) emotionality. Pregnancy itself and the later arrival of the infant may 
buffer against the negative effects of HIV infection on the woman’s emotional health; or 
for the newly diagnosed, the negative impact may delay timely access into prenatal care 
(Tariq et al. 2012). However, three months postpartum, Kotze et al. (2013) observed the 
fading of the beneficial effect of pregnancy and motherhood on the active coping 
behaviors (e.g. maternal medication adherence or follow up with pediatric clinic visits for 
the infant) in 224 South African women diagnosed with HIV during pregnancy. Six 
months after diagnosis, the women reported an increased use of avoidant coping 
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behaviors (Kotze et al.); and six months after delivery, 57.5 % of 300 South African 
women testing positive to HIV during pregnancy discontinued care (Clouse et al., 2013).  
Furthermore, the woman’s ability to manage a complicated disease and its 
prescribed treatment (i.e. maternal health behaviors indicated for either pregnancy and/or 
HIV disease) may be further compromised by environmental and societal macro-
structural challenges beyond her control. These include delayed diagnosis, poor access to 
care and ART, competing priorities related to the woman’s caregiver role and social 
location, HIV-related stigma, drug use, poverty, intimate partner violence, lack of social 
support, low educational attainment, and psychological distress (Kates et al., 2013; 
Lachat et al., 2006; Watkins-Hayes et al., 2012). Individual coping with an HIV diagnosis 
in the presence of pregnancy is embedded in an array of psychosocial variables and 
macro-structural forces, any of which could, in turn, influence coping positively or 
negatively (Kotze et al., 2013). After birth, even if transmission has been prevented, these 
mother-infant dyads continue coping with the same or exacerbated family and 
environmental conditions that led to poor maternal health behaviors during pregnancy, 
now leading to disruptions in the mother-infant relationship, or even, possibly infant 
medical or other forms of child neglect. For example, some of these new mothers may 
struggle with symptoms of depression and/or anxiety while caring for their new infant. 
Simultaneously, they may count on few protective factors or resilience resources (such as 
a wide network of family and friends) to counterbalance their emotional distress, promote 
the use of optimal maternal health behaviors and protect their infants from neglect 
(Dunkel Schetter, 2011; Landy & Menna, 2006; Oswalt & Biasini, 2012; Warner et al., 
2003). Furthermore, mothers who attend mental health or drug use services may reduce 
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their emotional distress and perhaps alleviate their addiction; however, these 
interventions may not be enough to effectively optimize their caregiving behaviors and 
prevent child neglect. Infants born to HIV-infected women with high rates of substance 
use problems and psychological distress could be more likely to be neglected (Oswalt & 
Biasini). The disproportionate number of minority, low-income women diagnosed with 
HIV, the social isolation frequently resulting from HIV-stigma, and the incidence of 
domestic violence related to partner disclosure of their HIV status place these mothers 
and their infants in situations with a high potential for disruptions in caregiving, and/or 
higher risk for child maltreatment (Machtinger et al., 2012; Oswalt & Biasini). 
Antiretroviral adherence. HIV-infected pregnant women have reported higher 
rates of adherence across different types of ART regimens during pregnancy compared to 
the postpartum period (Bardeguez et al., 2008; D’Auria et al., 2006; Ickovics et al., 2002; 
Kreitchman et al., 2012; Nachega et al., 2012). None of these national and international 
surveys of pregnant women with HIV/AIDS measured the relationship between maternal-
fetal attachment and ART adherence. Nonetheless, they reported that the health of the 
fetus, the desire to protect the fetus from their own infection, and the motivation to 
prevent mother-to-child transmission were the primary reasons women offered to account 
for their better adherence during pregnancy, compared to the period after childbirth 
(Ekama et al., 2012; Mellins et al., 2008; Michel et al., 2012; Nachega et al.). Similar 
themes, such as getting tested and adhering to ART medication early in pregnancy to 
protect the health of the fetus and/or proactively guard the women’s own health, clearly 
emerge among the findings of two, one national another international, qualitative studies 
(Kelly et al., 2012; Njie-Carr et al., 2012). The explanations and themes expressed by 
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HIV-infected pregnant women participating in these studies closely allude to their 
experience of maternal-fetal attachment. Kelly et al. (2012) indicate that the themes of 
“motherhood” and “hopes for the new life of the unborn child” become a source for 
optimism and motivation to practice optimal maternal health behaviors, in the context of 
adversity. The present study used maternal-fetal attachment to conceptualize these 
themes and tested the hypothesized facilitative influence of maternal-fetal attachment on 
maternal health behaviors, before and after childbirth, in this population.   
 Adherence to ART among pregnant women diagnosed with HIV/AIDS has been 
extensively researched in the U.S. Demas et al. (2005) found a positive association 
between progressive gestational age and short-term adherence among a subset of 78 HIV-
infected pregnant women participants of the New York City Perinatal HIV Transmission 
Collaborative Study.  Mellins et al. (2008) and Bardeguez et al. (2008) found that 
advanced HIV status, higher viral load, more overall health- related symptoms, and 
alcohol, tobacco or marijuana use were positively associated with medication non-
adherence; or negatively associated with “perfect adherence.”  Bardeguez et al. observed 
that “never missing prenatal vitamins” was the only factor significantly associated with 
perfect adherence to ART in pregnancy. This finding suggests that adherence to prenatal 
care may permeate or parallel ART adherence. Laine et al. (2000) found that young, 
minority and urban HIV-infected pregnant women had greater risk for poor ART 
adherence. Previous research reported mixed findings on whether initiating ART during 
or before pregnancy contributes to better medication adherence (Bardeguez et al.; Laine 
et al.).  
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Additional contextual psychosocial risk factors and macro-structural forces 
contributing to problematic ART adherence among women living with HIV/AIDS 
include: advanced HIV disease, use/history of illegal drugs, homelessness, decreased 
number of prenatal visits, mental health problems, avoidant coping, intimate partner 
violence, less disclosure of maternal HIV status to children, increased parenting stress, 
and single parenthood (Kates et al., 2013; Mellins 2008; Sandelowski 2009; Watkins-
Hayes et al., 2012). For example, the language, educational, and economic difficulties of 
the foreign-born HIV-infected women of Rhode Island compromise their ability to adhere 
with prescribed medication regimens and prenatal or postnatal follow up visits (Firth et 
al. 2012). Riley et al. (2011) found that among the population of unstably housed HIV-
infected women in San Francisco, California, unmet subsistence needs most strongly 
influenced their mental and gynecological health, relegating ART adherence to a lesser 
priority.  
Substance use. The prevalence of substance abuse pre- and during pregnancy 
among HIV-infected women is high enough to indicate concern for its effect on the 
women’s health, health behaviors and overall wellbeing (Bardaguez et al., 2008; Ethier et 
al., 2002).  Mothers with history of drug use diagnosis, compared to those without this 
history, reported stronger effect of avoidant coping on psychological distress, and 
employed larger support networks as a means of coping (Burns et al., 2008). However, 
women with a history of drug abuse did not benefit as much from the increased social 
support, as did those without this history (Burns et al., 2008). Mellins et al. (2002) found 
that a diagnosis of psychiatric or substance abuse disorders and parenting stress strongly 
correlated with ART non-adherence in a cohort of HIV-infected mothers living in a U.S. 
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inner-city setting. Those mothers who reported a diagnosed psychiatric or substance use 
disorder, negative stressful events, more household members, and parenting stress 
struggled with long-term adherence issues; they missed either taking their  medications 
and/or attending their medical appointments (Mellins et al., 2003). Additionally, in the 
long-term, baseline substance abuse diagnosis and lack of disclosure of their HIV status 
to family were associated with missed pills and missed medical appointments, 
respectively (Mellins et al., 2003). In the population of unstably housed HIV-infected 
women, drug use has the most empirical influence on their physical health, rather than the 
most influential factors of income, race, and education among the general population in 
the U.S. (Riley et al., 2011).   
Social support. In contrast to the studies reviewed earlier, which examined risk 
factors or macro-structural barriers for medication adherence, research examining social 
support, mostly defined as active coping, has led to the identification of protective factors 
against poor health practices among the population of pregnant women: disclosure of 
HIV status to women’s mothers, participation in support groups, and greater perceived 
availability of social support (Demas et al., 2005). Less disclosure of their HIV diagnosis 
to the children and single parent status correlated with missing medical appointments 
among HIV-infected mothers (Mellins et al., 2003). 
The social support that a woman receives during pregnancy may facilitate access 
to prenatal care and promote adherence with HIV treatment regimens (Demas et al., 
2005; Dunkel-Schetter, et al., 2001). This conclusion is consistent with research findings 
on social support in the pregnancy literature; specifically, the support a pregnant woman 
receives from the infant’s father most effectively lessens stress, anxiety and depression, 
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and promotes better utilization of prenatal care (Dunkel-Schetter et al., 2001). The 
women carefully choose to disclose their HIV status to those family members or friends 
who will offer support and suppress disclosure when they fear some form of retribution, 
including partner violence and withdrawal of emotional or financial support (Njie-Carr et 
al., 2013). 
Napravick et al. (2000) found lack of support along with unplanned pregnancy, 
poverty, periodic homelessness, addiction to illicit substances, perceptions of the health 
care system as threatening, and HIV-related mental health problems (e.g., self-reported 
depression and isolation) as the most important barriers to access prenatal care. 
Conversely, support from health professionals along with the availability of treatment 
emerged as the most prominent facilitating factor (Napravick et al.).  
Qualitative studies conducted in Kenya and Brazil on women coping with a 
diagnosis of HIV during pregnancy and after childbirth identified that strong, multi-level 
social support networks (e.g. intrapersonal, interpersonal, community, and health care 
system) facilitated the women’s ability to overcome recurrent episodes of depression, or 
bring their infants to the pediatric HIV care clinic (Jerome et al., 2012; Wachira et al., 
2013).  
Summary. In sum, research on the health behaviors of pregnant women with 
HIV/AIDS in the U.S. has emphasized barriers to ART adherence, while neglecting 
contributors to prenatal self-care during pregnancy and infant care after delivery. Most 
quantitative and qualitative studies on pregnant women with HIV/AIDS emphasize risks 
for adverse pregnancy outcomes related to non-adherence to HIV ART, especially the 
risk of mother-to-child transmission of HIV infection. In contrast, few studies examine 
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adherence facilitators reported by HIV-infected pregnant women, such as adequate 
prenatal care, appraisal of the pregnancy as a “life transforming event,” support from her 
sexual partner, and concerns about the fetus’ or newborn’s welfare. For example, Mellins 
et al. (2008) found that women were more likely to attribute their baby’s state of health to 
their better ART during pregnancy than post-partum. D’Auria et al. (2006) noted that 
“the infant is an important source of support and hope for mothers with HIV infection, 
often becoming their reason to live and take better care of themselves” (p. 16). 
Researchers generally emphasize risk factors over protective factors—the latter limited to 
accessing prenatal care and adhering to ART regimens.  
Maternal-Fetal Attachment in Women with HIV/AIDS 
Ethier et al. (2002) measured levels of maternal-fetal attachment among HIV-
infected pregnant women when they evaluated the implementation of Public Health 
Service guidelines regarding the prevention of perinatal HIV transmission, and assessed 
the psychosocial consequences of HIV infection among pregnant women. They observed 
that HIV-infected women scored significantly higher than their uninfected pregnant peers 
on the Maternal-Fetal Attachment Scale (MFAS; Cranley, 1981), and were more likely to 
report having been actively trying to prevent a pregnancy. Ethier et al. opined that 
although the HIV diagnosis preoccupied these pregnant women in terms of transmission, 
it might also give them extra motivation to practice safe sex and deepen attachment to 
their fetuses. 
The unique relevance of maternal-fetal attachment. Whereas accessing 
adequate prenatal care and other specialty HIV, mental-health and/or substance abuse 
treatment may reduce the risk to the dyad of adverse pregnancy outcomes (e.g., low birth 
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weight, premature birth); it may not shield women and infants against poor maternal 
health behaviors and suboptimal infant care. Here, nurturing mother-infant relationship 
and skillful parenting count among the protective factors when the risk for child 
maltreatment is high (Counts et al., 2010; Warner et al., 2003). Maternal-fetal attachment 
describes “the extent to which women engages in behaviors that represent an affiliation 
and interaction with their unborn child” (Cranley, 1981, p. 282). Protection is also 
conceived as the overpowering emotion in maternal-fetal attachment: the fetus is 
perceived as belonging exclusively to the women, dependent on her for life itself 
(Sandbrook, & Adamson-Macedo, 2003). Thus, the protective attributes of caregiving 
towards the infant may stem from a strong maternal-fetal attachment (Counts et al.). As 
conceptualized in this study, maternal fetal attachment simultaneously relates to maternal 
caregiving and attachment relationships. It emphasizes that maternal caregiving and 
mother-infant attachment begin when the child is only a fetus (Ahern & Ruland, 2003; 
Smith, 2010).  
The expression “maternal-fetal attachment” was coined by Cranley (1981) who 
created the Maternal-Fetal Attachment scale (MFAS) to measure this prenatal 
relationship. However, the concept has been used for decades in nursing research to 
describe this connection between a pregnant woman and her unborn child. For example, 
Rubin’s (1967) research on the maternal developmental tasks of pregnancy includes the 
woman binding to her unknown child and learning to give of herself. Indeed, the original 
MFAS subscales correspond theoretically to Rubin’s theory of maternal role attainment, 
measuring (a) differentiation of self from fetus, (b) interaction with fetus, (c) attributions 
of characteristics and intentions to the fetus, (d) giving of self and (e) maternal role taking 
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(Ahern & Ruland, 2003). Five items in the MFAS “address maternal behaviors ensuring 
the welfare of the developing fetus” (Grace, 1989, p. 231). Arguably, the maternal-fetal 
attachment is an adult attachment unique to pregnant women.  
Bowlby and Ainsworth’s attachment theory describes the mother-infant 
attachment relationship as instinctual, and organized by the infant’s need for proximity to 
a caregiver who will provide ongoing safety and protection (Bowlby, 1969; Bretherton, 
1992). Maternal-fetal attachment describes a unique adult attachment during pregnancy 
in which any maternal instinct or disposition to protect the fetus may promote behavioral 
changes to ensure a favorable intrauterine environment and eradicate threats to fetal 
wellbeing (Lewis, 2008; Sandbrook, & Adamson-Macedo, 2003). Maternal-fetal 
attachment is seen in this study as a prenatal protective relationship, most likely 
unfolding since the beginning of pregnancy, the possible precursor of maternal caregiving 
towards the end of pregnancy (Solomon & George, 1996).  
In sum, the concept of maternal-fetal attachment examined in combination with 
HIV-infected pregnant women’s health behaviors introduces an innovative relational, 
developmental approach to the study of the HIV-affected mother-infant dyad in its very 
beginning, and of available protective factors against poor maternal health behaviors and 
infant neglect in this population. This approach highlights maternal-fetal relationship as 
the predecessor of mother-infant attachment. Maternal-fetal attachment may be an 
already existing protective factor for these multi-risk mother-infant dyads that can be 
used to prevent child maltreatment (Shonkoff & Phillips, 2000). The socio-ecological and 
strengths-based approach of child development in this study explores the potential 
protective role of maternal-fetal attachment for mother-infant dyads coping with 
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HIV/AIDS, whose attachments are disrupted by this chronic illness and multiple other 
environmental risks. Maternal-fetal attachment also expands the inquiry on maternal 
health behaviors to the mother-infant relationship. Protection and relationship underscore 
the importance of the child’s early years to shape future development.  
Theoretical Link Between Maternal-Fetal Attachment and Health Behaviors 
While theoretically linked, empirical tests of the interaction between maternal-
fetal attachment and maternal health behaviors in populations other than women with 
HIV, or in homogeneous or low-risk samples, provide mixed results (Van den Bergh & 
Simons, 2009). Variations in measures of maternal-fetal attachment or maternal health 
behaviors, definitions of key concepts, timing of assessments during pregnancy, and 
number or type of predictor variables may explain the inconsistencies. Lindgren (2001, 
2003) assessed that high levels of maternal-fetal attachment were associated with 
increased participation in high-quality health practices among low-risk, middle- aged 
pregnant woman. In contrast, other studies have found positive associations between 
maternal-fetal attachment and smoking and use of cocaine/heroin during pregnancy (Van 
den Bergh & Simons). Yet, four comprehensive reviews on maternal-fetal attachment 
(Alhussen, 2008; Cannella, 2005; Laxton-Kane & Slade, 2002; Van den Bergh & 
Simons) identify the relationship between this prenatal relationship and health practices 
during pregnancy as a critical knowledge gap and recommend exploring this association 
among vulnerable and culturally diverse populations of pregnant women. 
As influential as maternal-fetal attachment may be on HIV-infected women’s 
health behaviors, this prenatal attachment is expected to be influenced by the woman’s 
family, community, and larger socio-ecological environment (Bronfenbrenner, 1979). 
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Among uninfected, predominantly white pregnant women, Lindgren (2001) found that 
higher levels of education, less children, and living with a partner predicted more high-
quality health practices. Furthermore, the finding that lower levels of depression and 
higher levels of maternal-fetal attachment were significant predictors of positive health 
practices seems to support the argument of the present study. Lastly, Lindgren (2003) 
observed the association between high level of maternal-fetal attachment and better 
health practices only for participants from the inner city, not for those from small urban 
communities. Relevant to this study, Lindgren (2003) suggests that for inner city 
residents “strong maternal-fetal attachment… may be a powerful motivator, enabling her 
to overcome barriers to positive health practices” (p. 318).    
Balance in risk and protection. The child maltreatment literature identifies 
several maternal and environmental risk factors among mother-newborn dyads during the 
perinatal period, which broadly comprises a year before and 18 to 24 months after the 
birth of a child (Hefner, 1987). Two major population studies concur on key risk 
variables in this developmental stage: infants whose mothers smoked during pregnancy, 
were unmarried, Medicaid beneficiaries, and had two or more children were more likely 
to be maltreated, as per definition of abuse and neglect in public child protective services 
records from Florida and Georgia states (Wu et al., 2004; Zhou et al., 2006).  
More specific to this study, Nair et al (1997) examined risk factors for early 
disruption in primary caregiving among a cohort of drug using mothers in the Baltimore 
area. They found that infants of younger mothers who were heroin users, had two or more 
children, had other children in foster care, and reported depressive symptoms were more 
deprived of ongoing primary care than their population average (Nair et al., 1997). 
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Remarkably, several of the risk factors for infant maltreatment identified in these three 
studies coexist among HIV-infected pregnant women.  
Research on what protects infants from maltreatment in relatively higher-risk 
contexts, though less prolific, is equally compelling. Most of it has investigated early 
care, education, and home-visitation programs that embrace the guidelines of the 
Strengthening Families Initiative work of the Center for the Study of Social Policy 
(Counts et al., 2010). McLeod and Nelson’s (2000) meta-analysis reviewed 56 programs 
designed to promote family wellness and prevent child maltreatment. Proactive programs 
begin prenatally, at birth, or during early infancy, while reactive programs usually begin 
when the child enters school. The findings suggest that interventions with an 
empowerment, strength-based approach have superior results; the earlier the intervention 
the better; and proactive programs may trigger family life trajectories that break 
downward spirals of child maltreatment (McLeod & Nelson, 2000).  
Additionally, Counts et al. (2010) identified five malleable protective factors 
against child maltreatment commonly addressed in these prevention programs (a) family 
functioning, (b) emotional support, (c) concrete support, (d) nurturing and attachment, 
and (d) knowledge of parenting and child development. Specific to  the prevention of 
child neglect, DePanfilis & Dubowitz (2005) assessed promising outcomes for the Family 
Connections program to prevent child neglect by helping families maximize parenting 
attitudes, sense of competence, family functioning and social support (i.e., protective 
factors), and decrease caregiver depressive symptoms, parenting stress and everyday 
stress (i.e., risk factors). Maternal-fetal attachment—the immediately available 
relationship developing during pregnancy—may constitute an unexplored protective 
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factor against poor post-natal maternal health behaviors leading to infant medical neglect 
in the lives of HIV-infected women.   
Clinical advances in the treatment of HIV mean that one should now look beyond 
reducing adverse pregnancy outcomes, to enhancing maternal wellbeing and promoting 
wholesome attachments and nurturing home environments. As HIV-affected families 
adapt successfully to both a new infant and a chronic illness, they can be expected to 
create “upward” spiral trajectories, free of disrupted caregiving, enhanced by desirable 
maternal health behaviors, strong attachments and competent caregiving. Yet, researchers 
are only starting to examine the optimal long-term mother-infant interaction trajectories 
for these families; unfortunately they focus only on maternal risk factors which may 
result in suboptimal infant outcomes, neglecting to study protective factors during this 
salient developmental stage (Oswalt & Biasini, 2010). Researchers must study the 
protective effects resulting from these women’s maternal bonding during the perinatal 
period, which may balance well known risk factors.  
Building an ecological model of infant neglect. Child neglect is the most 
commonly reported and substantiated type of child maltreatment, yet criteria to define it 
remain controversial (English et al., 2005). Legal definitions of child neglect emphasize 
specific parental omissions in adequate care and observable harm or risk for harm. 
Alternatively, English et al. conceptualize child neglect as the impact of omissions in 
caregiving on age-specific basic developmental needs of infants, toddlers and 
preschoolers (p. 194). English et al.’s developmental child-centered definition aligns with 
an ecological definition of child maltreatment and the theoretical framework employed in 
this study. In this model of child neglect, infants who lack nurturance and protection are 
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vulnerable to disturbances in attachment and future impaired social interactions; and 
parental blame for omissions in care is replaced by the consideration of individual, 
family, community and societal risk and protective circumstances that influence parental 
caregiving and contribute to reduce the risk of child neglect (Dubowitz et al., 1993). 
Theoretical Framework of this Study 
The intersection of pregnancy and HIV, two major life events, challenges women 
to respond with defeat or transformed adaptive abilities to either or both (Jones, 2008; 
Saleebey, 1992). HIV diagnosis per se is not associated with poor maternal attachment or 
disrupted self-care; rather, severe illness (AIDS), poverty, substance abuse, emotional 
distress or the lack of supports converge in the lives of HIV-affected families to place 
them at increased risk for poor maternal health behaviors and infant neglect (Fair, 2006; 
Long, 2009). Access to prenatal care and available social support from the pregnant 
women’s mother and marital partner may counterbalance vulnerability and protect 
against risks.    
Socio-ecological theory underscores the influence of social contexts on human 
development as surrounding adults in different family or community roles interact with 
the HIV-infected mother and her infant (Bronfenbrenner, 1992, cited in Olds et al., 1997). 
This approach views pregnancy and childbirth as an opportune time to prevent multiple 
adverse maternal, child, and family outcomes, including child maltreatment (Olds et al., 
1997). For example, home visiting programs for low-income first time pregnant women 
and parents of young children emphasize parental development and parenting behaviors 
as the primary focus of the preventive intervention (Olds et al., 1997). They address risk 
and protective factors within the evolving mother-infant relationship and the multiple 
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contexts in which the family functions. Of particular relevance to this study, they 
highlight parents’ health- and caregiving-behaviors as the most powerful and potentially 
alterable influence on developing infants (MacLeod & Nelson, 2000). 
 In the larger macro-structural context, pregnant women with HIV/AIDS are 
assumed to have control over the prenatal environment (i.e., maternal-fetal attachment, 
maternal health behaviors), the direct interaction with their infant postnatally (i.e., 
mother-infant attachment and caregiving behaviors), and to contribute to the home 
environment (Olds et al., 1997). However, the additional burden they bear in coping with 
a chronic and stigmatizing disease within their families and communities hinders their 
ability to exercise such control effectively (Watkins-Hayes et al., 2012). The 
biospychosocial model of maternal stress processes in pregnancy (Dunkel Schetter et al., 
2011) conceptualizes maternal health behaviors within the continuum of psychosocial 
risk and resilience specific to pregnancy, and also points to current knowledge gaps in 
building models of resilience for pregnancy and birth (Dunkel Schetter et al., 2011).  
Protection in maternal-fetal attachment and maternal health behaviors. The 
logic connecting the perinatal period with protection for the mother-infant dyad starts 
with framing at once maternal-fetal attachment, maternal health behaviors, and optimal 
infant care within a socio-ecological model of child development (Bronfenbrenner, 1979; 
English et al. 2005; Shonkoff & Phillips, 2000). In this framework, the prevention of 
something negative (less protective maternal health behaviors and sub-optimal infant 
outcomes) requires the prior enhancement of something positive (strong maternal-fetal 
and mother-infant attachments; Helfer, 1987).  Enhanced maternal-fetal attachment and 
strengthen mother-infant relationship may help prevent less protective maternal health 
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behaviors, including disruptions in care for the physical health and safety, emotional 
security, and social integration of infants (English et al.; Helfer).   
Protection of the fetus is the core emotion and altruistic function in several 
definitions of maternal-fetal attachment as a relational construct that marks the beginning 
of the mother-child relationship (Sandbrook & Adamson-Macedo, 2003; Yarcheski et al., 
2009). According to this reasoning, as pregnant women transform into mothers, they shift 
from seeking to be protected (attachment behavioral system) to striving to protect the 
infant (caregiving behavioral system) (Solomon & George, 1996). In this prenatal 
relationship, a protective “instinct” motivates changes in the mother’s health behaviors to 
secure a nourishing intrauterine environment, reducing threats to the unborn child’s 
wellbeing. Thus, theoretically, during the perinatal period, maternal-fetal attachment 
blends with known protective factors against infant neglect: adequate prenatal care, 
nurturing parental attachment behaviors, and responsively sensitive parenting (Shonkoff 
& Phillips, 2000). 
To delay disease progression in the mother and prevent mother-to-fetus HIV 
transmission, these women must receive concurrent prenatal and HIV care, including 
physical examinations and laboratory monitoring (Lachat et al., 2006). Nonetheless, 
research reveals inconsistent and problematic health behaviors in pregnant women with 
HIV, especially during the postnatal period when the family, medical and community 
attention extant in the prenatal period has ceased or diminished (Bardeguez et al., 2008; 
Ickovics et al., 2002; Wood et al., 2004). An unsteady transition to the postnatal stage 
places the HIV-infected mother at risk for postpartum depression, HIV-related 
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posttraumatic stress, domestic violence or relapse in substance abuse, all of which disrupt 
the parental caregiving role and mother-infant relationship. 
Conversely, research findings on pregnant women living with HIV/AIDS reveal 
that they adhere better to medication, are less depressed, and function at a higher level 
than HIV-infected women who are not pregnant (Bardeguez et al., 2008; Mellins et al., 
2008; Swartz et al., 1998). When compared to their uninfected counterparts, they report 
significantly lower rates of recent and current use of hard drugs, higher levels of MFA, 
and safer sex practices after childbirth (Ethier et al., 2002; Smith et al., 2001). Pregnancy 
affords a woman the opportunity to reappraise pre-pregnancy and HIV-related stressors 
and practice more adaptive coping, possibly explaining the apparent advantages for HIV-
infected pregnant women. Alternatively, for them pregnancy may demand different 
coping responses, which in turn positively impact coping outcomes (i.e., health 
behaviors). The proposed study examines the protective influence maternal-fetal 
attachment may exert on HIV-, pregnancy-, and infant-related health behaviors among 
pregnant women living with HIV/AIDS. The desire to protect their fetuses from the threat 
of transmission might motivate these women to improve ART adherence specifically, and 
pregnancy-related health behaviors generally (Ciambrone et al., 2007; Mellins et al., 
2008).  
Definitions of Key Constructs Used in this Study 
Maternal-fetal attachment (MFA). This construct defines the affectionate 
relationship that pregnant women develop for their unborn child, manifested through 
behaviors, thoughts and feelings showing care and commitment to the fetus. The 
woman’s ability to see her fetus by ultrasonographic techniques and to perceive fetal 
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movement (i.e., “quickening”), in the second trimester of pregnancy (i.e., 14 to 27 
weeks), deepens maternal-fetal attachment (Cohen & Slade, 2000; Canella, 2005). This 
prenatal attachment therefore appears as a key developmental task in pregnancy and the 
transition to motherhood. The pregnant woman evolves to see herself as someone who 
can nurture and comfort her child and provide a secure base for her child (Cohen & 
Slade; Laxton-Kane, 2002). Conceptually, maternal-fetal attachment includes: a) the 
desire to know the unborn child, b) the pleasure related to interactions with the unborn 
child, and c) the desire to protect the fetus (Yarcheski et al., 2009). An HIV-infected 
pregnant woman may derive pleasure from interacting with her unborn child, may wish to 
know it and may protect it by staying healthy.  
Social work researchers Lewis (2008) and Feldman (2007) extend the study of 
maternal-fetal attachment to different high-risk populations of poor and ethnically diverse 
women; pregnant women who consumed alcohol and pregnant adolescents, respectively. 
Their findings emphasize the role of the environment, and maternal or fetus 
characteristics in the intensification of maternal-fetal attachment. Ahern and Ruland 
(2003) performed comparative analyses of maternal-fetal attachment scores for African 
American and Hispanic pregnant women, two culturally distinct groups. While they 
found differences in the Giving of Self and Attributing Characteristics to Fetus subscales 
of the MFAS (Cranley, 1981), socio-demographics rather than culture may account for 
the findings. The impact of culture on maternal-fetal attachment remains unknown and 
needs further research. 
In sum: a) the core experience of maternal-fetal attachment is the desire to protect 
the fetus from harm; and b) consequently, women develop motivation throughout the 
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pregnancy to adhere to all necessary maternal prenatal health behaviors (Sandbrook & 
Adamson-Macedo, 2004). Moreover, when assessing maternal-fetal attachment 
predictors diverse factors may show different priorities, contingent to the demographic 
and contextual characteristics of the population under study.  
Pregnancy health behaviors (i.e., pregnancy care). Pregnancy care describes 
the actions a pregnant woman takes that may positively influence health and pregnancy 
outcomes (Lindgren, 2003). Abstaining from tobacco, alcohol and illegal drugs, obtaining 
prenatal care, eating nutritiously and gaining the appropriate amount of weight, getting 
regular exercise, and learning about pregnancy and childbirth are examples of high-
quality health behaviors.  
HIV-related health behaviors (i.e., prenatal ART and infant care adherence). 
These behaviors consist of adherence to ART for maternal health, and for prevention of 
HIV mother-to-child transmission during pregnancy; and after childbirth, adherence to 
infant screening clinic appointment schedules for pediatric HIV care.  
Research Hypothesis 
Maternal-fetal attachment, history of substance use, marital relationship status, 
planned pregnancy status, and timing of HIV diagnosis will independently predict three 
maternal health behaviors in pregnant women with HIV: pregnancy care, prenatal ART 
adherence, and infant care adherence.   
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CHAPTER III: METHODOLOGY 
Study Design  
 
This study employed a 17-month prospective observational design to examine 
relationships between maternal-fetal attachment and pre- and post-natal health behaviors 
in HIV-infected pregnant women, while taking into account four other potential theory-
based predictors of health behavior: history of drug use, marital relationship status, 
planned pregnancy status, and timing of HIV diagnosis. 
Study Setting 
PRIM and Screening clinics. This project took place in the Miami Family Care 
Program’s Prenatal Immunology (MFCP’s PRIM) clinic of the OB/GYN Department, 
and the infant screening (Screening) clinic of the Pediatrics Department, both located at 
the University of Miami’s Miller School of Medicine. Most family practice providers, 
obstetricians, federally-qualified health centers, public health clinics and other perinatal 
programs throughout Miami Dade County in Florida identify and refer HIV-infected 
pregnant women directly to the PRIM clinic for concurrent prenatal and HIV care. The 
PRIM perinatal health care team offers prenatal care and ART management following 
standard of care recommendations from the U.S. Department of Health and Human 
Services Panel on Treatment of HIV-infected Pregnant Women and Prevention of 
Perinatal Transmission (US DHHS Panel on treatment of HIV-infected Pregnant Women 
and Prevention on Perinatal Transmission, 2011). Women also receive ART adherence 
counseling, mental health assessments and behavioral management sessions on stress 
reduction and partner disclosure strategies.  
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After delivery, all mothers attending the PRIM clinic are instructed to enroll their 
newborn infants in the MFCP Screening Clinic, and bring them to all scheduled clinic 
visits for monitoring of the mother-to-child transmission of HIV. The pediatric screening 
team coordinates the care for the HIV-affected family by conducting psychosocial 
assessments, mental health interventions, and HIV counseling and testing for additional 
family members, as needed. Infants lacking health insurance also receive interim primary 
care services until they are linked to a primary care pediatrician. A non-breastfed infant is 
discharged from screening clinic after establishing definitive exclusion of HIV diagnosis 
based on two negative virological tests at age ≥  1 month and ≥  4 months. The Screening 
clinic completes the pediatric end of the standard protocol to reduce the mother-to-child 
HIV transmission risk (US DHHS Panel on Treatment of HIV-infected Pregnant Women 
and Prevention of Perinatal Transmission, 2011). 
PRIM and Screening clinic protocols. Routine prenatal care checkup visits 
occur once a month for weeks 4 through 28, every two weeks between weeks 28 to 36, 
and once a week from 36 weeks until delivery (Figure 1). However, participants may 
attend additional prenatal care visits to monitor their HIV viral load (one measurable 
outcome of medication adherence behavior after resolving viral resistance to ART), other 
medical conditions, or drug use. Specifically, according to the Panel on Treatment of 
HIV-infected Pregnant Women and Prevention of Perinatal Transmission (2011), HIV 
viral load should be monitored in this population at the initial prenatal visit, 2 to 4 weeks 
after starting or changing antiretroviral medication regimen, monthly until viral load 
levels are undetectable, at least every three months thereafter during pregnancy, and close 
to delivery at 34 to 36 weeks.   
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The HIV viral load accurately reflects burden of infection and the extent of viral 
replication; and once the woman starts antiretroviral medication, viral load is used to 
monitor the response to medication therapy because achieving a viral load below the 
level of detection (e.g., <40 copies/mL) is the main goal of this therapy to effectively 
prevent the transmission of HIV from mother to child (AETC, 2011).  
The screening clinic protocol consists of four clinic visits with infants at 2, 4, 6 
weeks, and 4 months of age (Figure 1). Specifically, virologic tests should be performed 
on infants born to HIV-infected women in the first two visits (2 and 4 weeks old), and the 
fourth visit (4 months old) to establish presumptive and definite HIV diagnosis exclusion, 
respectively (Panel on Treatment of HIV-infected Pregnant Women and Prevention of 
Perinatal Transmission, 2011). During the third visit (i.e., 6 weeks old), the infant’s ART 
prescribed at birth is discontinued and the parent is counseled on previous virologic test 
results. The screening clinic social workers are legally mandated to report to the local 
Department of Children and Families non-attendance of the infant to any screening 
appointment, and the information is recorded in the infant’s medical record. 
Participants  
Study participants were recruited from the women who attended the PRIM clinic 
between June 2012 and November 2013. Participants in this study were racially and 
ethnically diverse (67% Black or African-American, 33% White; 66% non Hispanic, and 
34% Hispanic), English- and Spanish-speaking pregnant women, at gestational age ≥ 24 
weeks (end of the second and beginning of the third trimester) who received prenatal care 
from the PRIM clinic while diagnosed with HIV, either during or before the index 
pregnancy. In 2012, at least 135 infants born in Miami-Dade County were determined to 
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have been exposed to HIV prenatally (PRIM/Screening, 2013). Of these infants, 114 
(84%) were born to women who attended the PRIM clinic until delivery, 16 (12%) 
received prenatal care in a different community obstetric clinic, and 5 (4%) received no 
prenatal care (PRIM/Screening). In 2012, an average of 9.5 births per month in the PRIM 
clinic; assuming each woman gave birth to one child and a similar rate would occur in 
2013. Then, during the study period 161.5 exposed children would have been born in 
PRIM clinic to 161.5 mothers, and the present study would have recruited 82 (51%) of 
them.  Extending this extrapolation to Miami-Dade County, 191.25 exposed children 
were born in Miami-Dade County, and the present study recruited 82 of them (43%).  
Inclusion/exclusion criteria. English- and Spanish-speaking women and 
adolescents of at least 24 weeks of pregnancy followed for pregnancy and HIV care, who 
delivered in PRIM, were eligible to participate in the study. Women were excluded from 
participation if monolingual in Creole because instruments were not translated into this 
language. This was estimated to affect approximately 6 women (PRIM, 2010). Women in 
whom the possibility of viral resistance to any of the medications in their ART regimen 
remained unresolved were also excluded from the study. 
Recruitment of participants. Following approval by the Florida International 
University and University of Miami Institutional Review Boards, pregnant women with 
HIV who met inclusion criteria were approached for recruitment by the principal 
investigator (PI) between July 2012 and November 2013. Weekly on Mondays, prior to 
the PRIM clinic on Thursdays, the PI joined the medical team pre-clinic meetings to 
access the clinic census and identify which women scheduled to attend in a given week 
met study inclusion criteria.  
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During this 17-month period straddling two consecutive years (a total of 68 
Thursdays), 110 eligible pregnant women arriving for their appointment were invited to 
participate in the study, following HIPAA and other medical care protocols practiced in 
the PRIM clinic. For example, any researchers recruiting from the PRIM clinic do not 
approach any woman during her first prenatal care visit, especially those newly 
diagnosed, because they may need confirmation of the HIV diagnosis, proper post-
diagnosis counseling, or psychological intervention to address the emotional turmoil that 
might have been prompted by the HIV diagnosis. The PRIM clinic database (2014) 
reported that 80 and 77 women received prenatal care and delivered their newborns in 
their facilities in the years 2012 and 2013, respectively. Of a total 157 women who 
attended PRIM clinic during the study period, 110 (70%) women were invited to 
participate, 28 declined and 82 were recruited. The numbers of participants across data 
collection Times 1, 2, and 3 (see ahead) were respectively 76, 65, and 53 (Figure 1 
flowchart). These numbers represent the participants included in the statistical analyses at 
each data point.  
Women who declined participation reported as reasons concerns about the privacy 
of their medical diagnosis, being reported to child protection authorities, and/or needing 
to consult the father of the unborn child. In addition, the emotional distress in newly- 
diagnosed women, preference to participate in research studies with greater financial 
incentive than this one, cognitive limitations to understanding the information about the 
study, or tentativeness about proceeding with the pregnancy were inferred from 
observations of PI as possible reasons for declining participation.   
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Figure 1. Sample flow chart for recruitment, enrollment, and subsample sizes.  
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 eligible women 
invited to participate 
82 recruited/enrolled 
74% recruitment rate
30 original 
protocol 
52 modified 
protocol 
76 Data collection  
 Time 1
65 Data collection  
Time 2
53 Data collection  
Time 3
28 declined participation: 
3 Privacy concerns about HIV dx 
2 Fear of report to child protection 
3 Consult with child’s father 
3 Other research study 
 3 No Interest 
14 No reason offered
6 excluded after enrollment: 
1 miscarriage 
1 false positive HIV dx  
4 < 24 wks gestation 
11 excluded during pregnancy: 
11 pending delivery 
12 infants excluded after birth: 
1 infant died  
11 incomplete screening 
protocol 
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Figure 2. Study design, measures and clinics protocol  
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            Figure 2. Prospective study design across data collection Times, study measures applied to each   
Time and clinic visits scheduled for participants by the Prenatal Immunology and Pediatric 
Screening clinics, following standard protocols for the prevention of HIV mother-to-child 
transmission. IV = independent variable; DV = dependent variable. 
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35 
 
Eight months after the start of the study, in February 2013, the recruitment 
protocol was slightly modified by the PI, in coordination with the PRIM clinic team, as 
follows: eligible women pregnant for less than 24 weeks were invited only to consent to 
future participation in the study. Those who agreed were approached again by the PI at 24 
weeks’ gestation or more to complete the collection of Time 1 data (Figure 2).  
The PI developed an Excel document to log enrolled participants, avoid 
enrollment duplication, track participants pending collection of Time 1 and/or Time 2 
measurement, and ensure matching of Time 1 and Time 2 data (Figure 2). Extended 
recruitment efforts and modified recruitment protocol maximized enrollment of 
participants.    
Sample size calculation. The sample size was calculated to test the hypothesis 
that those participants with strong maternal-fetal attachment would be at least twice as 
likely (≤ 90%) to have optimal outcomes on the most important indicator of protective 
behavior in this population (optimal ART adherence) compared to participants with poor 
maternal-fetal attachment (≤ 45%). For 80% power to detect a statistically significant 
difference (at p<.05 level, 95% confidence interval) between participants that 
demonstrated strong maternal-fetal attachment (estimated at 50% of the population) 
compared to participants that demonstrated poorer maternal-fetal attachment, a minimum 
of 90 participants (50% with strong MFA indicators) would be required (Dean et al., 
2012; Fleiss, 1981; Kelsey et al., 1996). According to PRIM statistics, approximately 99-
110 women per year receive prenatal care at this clinic.  It was anticipated that 90 or 
more participants would be recruited.   
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Data Collection  
Once a woman agreed to participate in the study, the PI obtained all necessary 
informed written consents and enrolled her on site immediately, later during that clinic 
visit, or at a later clinic visit. Timing of enrollment depended on priorities related to her 
medical care and the gestational age at the time of consent. Every participant reaching 24 
or more weeks of pregnancy completed the socio-demographic self-report, the MFAS, 
and the HPQ-II in one interview session in a quiet and private clinic office. Participants 
took 25 to 35 minutes to complete Time 1 study instruments, depending on their ability to 
read the survey items, their level of comfort to ask questions about themselves or the 
study instruments, and the assistance each required from the interviewer (Figure 2). For 
those women completing the informed consenting process, and the Time 1 study 
instruments during the same clinic visit; this one-time interview lasted 40 minutes or less. 
The PI administered study instruments to reduce occurrence of missing data. PI is 
experienced in conducting clinical and research interviews in English and Spanish, and 
had obtained a Responsible Conduct of Research training certificate. PI also obtained a 
Certificate of Confidentiality from the National Institutes of Health to provide additional 
privacy protection for participants in this study. Participants received $20 to complete 
Time 1 measures. Consent included permission for PI to retrospectively, immediately 
after delivery, access participants’ obstetric medical record, using the Maternal Chart 
Review form (Appendix A), in order to abstract the following laboratory/patient’s history 
data: date and reading of HIV viral load at last pre-delivery clinic visit, HIV disease stage 
classification, maternal age at delivery, and trimester in which participant entered 
prenatal care. (Time 2: pregnancy ART adherence measure; Figure 2).  
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Similarly, participants authorized PI to access, four to five months after birth, the 
pediatric screening clinic medical record of their infant, using the Infant Chart Review 
form (Appendix B), to abstract information on attendance to the HIV screening clinic 
(Time 3: infant care adherence measures; Figure 2). For 12 of the 65 (18 %) women who 
delivered preterm (< 37 weeks), and whose infants required additional hospital stay in the 
neonatal unit; Time 3 data collection included the HIV screening tests done while 
receiving neonatal inpatient care.   
Measures  
English-Spanish back translation of the study survey and scales by two different 
translators, one for the forward-translation and another for the back-translation, was 
undertaken to preserve the intent of the wording and conceptual equivalence of the 
instruments across cultures and languages. Each translator followed FIU IRB linguistic 
qualifications requirements and signed necessary Translation Affirmation forms. 
Translated instruments were administered to the 10 monolingual Spanish-speaking 
women consenting to participate in the study. The English and Spanish versions of the 
instruments were pretested with a small sample of pregnant women to identify any 
problems before employing them in the actual study. All instruments used in this study 
are appended to this dissertation.  
Maternal-fetal attachment. (MFA, independent variable) was assessed at study 
entry, during at least 24 weeks of pregnancy (Time 1, ≥ 24 week; Figure 3), with the 
Maternal Fetal Attachment Scale (MFAS, Appendix F). The MFAS is the best validated 
self-report instrument available (Cranley 1981), containing 24 items (each scored from 1-
5). Content validity was assessed by an expert panel and pregnant women during the 
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scale’s development and convergent validity was supported by its correlation (r=.72) with 
the Prenatal Attachment Inventory (Lindgren, 2001). Lindgren (2001) also reported a .85 
internal reliability coefficient for the MFAS in a sample of 252 mostly White, pregnant 
women of diverse socio-economic status living in two Midwestern urban settings. This 
instrument has been used extensively in nursing research with women of diverse racial, 
ethnic, and socioeconomic status. Reported Cronbach alphas for the total MFAS score in  
previous studies range between .76 and .92; however, clinical norms have not been 
published (Van den Bergh & Simons, 2009). Total possible score for this continuous 
ordinal scale ranges from 24 to 120; higher total scores indicate higher levels of maternal-
fetal attachment.  Cronbach alphas reported for three of the original subscales were below 
.69; thus, this study only analyzes the total scores of the MFAS (Van den Bergh & 
Simons). The Maternal Antenatal Attachment Scale (MAAS) and the Prenatal 
Attachment Inventory (PAI) are among the other best known scales measuring maternal-
fetal attachment. However, data to judge the psychometric properties of MAAS are 
scarce and further research is needed to examine the dimensions of maternal-fetal 
attachment measured by the PAI (Van den Bergh & Simons). 
Pregnancy care (dependent variable 1): This is defined as the actions a pregnant 
woman takes that may influence her health, the health of the fetus or pregnancy 
outcomes. It was measured at enrollment (Time 1, ≥  24 weeks) by the abbreviated (20 
items) Health Practices Questionnaire-II (Appendix G, HPQ-II; Lindgren 2005) 
containing items related to drug use, safe sex practices, diet, rest and exercise, and 
childrearing knowledge. Each item has 5 optional responses, ranging from 1 (never) to 5 
which indicates the highest possible frequency for that activity (e.g., always, daily). Total 
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possible scores for this continuous variable range from 20 to 100, higher scores indicating 
higher frequency or quality of health practices. Content validity was established by a 
satisfactory content validity index (.83), and reviews from clinical experts and pregnant 
women (Lindgren, 2005). Construct validity was supported by statistically significant 
correlations with three theoretically related measures (Lindgren, 2005). The internal 
consistency reliability of the original HPQ-II is .81 in a sample of 312 mostly White, 
adult pregnant women of high socioeconomic status (Lindgren). This scale needs further 
validation with women from diverse ethnic, racial and socioeconomic backgrounds.  
  Pregnancy ART adherence. (dependent variable 2): This is defined as the 
participant’s behavior of taking her ART as directed by the physician without missing 
doses, or taking lower doses than prescribed (Mellins et al. 2008). It is indirectly 
measured in this study by laboratory blood results of an HIV RNA PCR (an HIV viral 
load) extracted retrospectively from participants’ obstetric medical record of the last 
prenatal visit before delivery (Maternal Chart Review; Appendix A). This particular 
reading probably represents the most valid viral load measure after monitoring response 
to ART, and confirming absence of viral resistance to the ART regimen medications, and 
it has been correlated to long-term HIV medication adherence during pregnancy (Bartley 
et al., 2012; Cohn, 2008). In addition, when preparing for the delivery of an HIV-exposed 
infant, the obstetrician considers the biological measures of maternal treatment outcome 
taken at 36 weeks gestation, because this last viral load is the principal predictor of 
mother-to-child transmission (S. Yasin, personal communication, October 9, 2012; PRIM 
chief obstetrician and medical director).  
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The viral load is expressed as the number of copies of HIV-1 RNA per milliliter 
of plasma, where <20 or <50 copies/mL indicates an “undetectable HIV viral load,” and 
>20 or >50 copies/mL indicates “detectable HIV viral load.” The two cut-off points to 
measure detectable viral load relates to the different sensitivity of the HIV tests used to 
detect and quantify the HIV viral load (< 50 v. < 20; Cobbs et al., 2011). This cut off 
range of viral load detection was used to categorize this dependent variable into perfect 
(< 20 or < 50), high (< 1,000), medium (1,000-10,000) and low (≥10,000) medication 
adherence (AETC, 2011; Mellins et al. 2008; S. Yasin, personal communication, October 
14, 2012). Dummy coding for the pregnancy ART adherence variable was used as 
follows: perfect adherence = 1, high adherence = 2, medium adherence = 3 and low 
adherence = 4. Categorizing this dependent variable and collecting information on viral 
resistance testing from the women’s medical record allowed for a more accurate measure 
of ART adherence. In determining eligibility, women with a known record of persistent 
unresolved possibility of antiretroviral resistance were excluded from the study. 
Infant care adherence (dependent variable 3): Information on attendance to all 
four screening clinic visits by each mother-infant dyad (i.e., completion of HIV screening 
protocol) was extracted from pediatric records four to five months after childbirth (Infant 
Chart Review; Appendix B). Attendance to infant’s screening clinic visits was counted 
on a ratio scale (0, 1, 2, 3, or 4 attendances) and treated as a continuous variable.  
Predictor variables. Participants were surveyed at study entry on the following 
personal characteristics: marital partner or not status, history of drug use or not, actively 
planned or unplanned pregnancy (includes actively preventing), and HIV diagnosis  
during or before index pregnancy (Socio-Demographic Survey– four items indicated by 
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*; Appendix C). For the data analyses, discrete predictor variables were dummy coded 
using “1” for the response group and “0” for the reference group as follows: history of 
drug use = 1 and no history of drug use = 0, with partner= 1 and without partner= 0, 
planned=1 and unplanned= 0, HIV diagnosis during pregnancy = 1 and before 
pregnancy=2. “Problems with partner” variable was measured by a single question 
requiring a “yes” (yes=1) or “no” (no=0) answer, and those participants responding 
“living with partner” were coded as with partner, regardless of the response to the marital 
partner status (i.e., single or married) and the problems with partner (i.e., problem or not) 
variables.  
Sociodemographic variables. In addition, maternal age, level of education, 
annual household income, race, ethnicity, gestational age, number of previous 
pregnancies, and number of live births, were recorded in a brief self-report form at study 
entry (Socio-Demographic Survey; Appendix C). Trimester of entry into prenatal care, 
maternal age at delivery, CDC classification of HIV disease stage (HIV infection or 
AIDS), and number of years since HIV diagnosis were abstracted from the participant’s 
medical record after delivery (Maternal Chart Review, Appendix A).  
Data preparation. At enrollment, each participant was assigned a unique 
personal number (PID) to anonymize all self-reported and medical record abstracted data. 
The PID number was written on each of the following: Socio-Demographic Survey, 
MFAS, HPQ-II, Maternal and Infant Chart Review forms. The PI’s tracking Excel 
document contained the participants’ name and corresponding PID. This list and signed 
consent forms were kept under lock and key in the PI’s office at UM Mailman Center for 
Child Development. Study forms containing self-reported and medical record abstracted 
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information will be kept secured in separate locked file cabinets located in the PI’s office 
for at least three years after completion of the study, and will be afterward destroyed. The 
anonymized data from interviews and chart review forms were entered for computerized 
analyses into a desktop computer in PI’s office. This computer is password protected, and 
only the PI had access to the raw data.  
Data Analysis  
Analysis proceeded in three steps using the Predictive Analytic Software (PASW) 
Statistics for Windows, Version 18.0 (SPSS Inc, 2009) to compute bivariate and 
multivariate statistical analyses. First, data screening procedures and preliminary analyses 
were performed to examine accuracy of data entry, fit between distribution of variables 
and assumptions of multivariate analyses, missing data, and outliers. Second, descriptive 
statistics were used to depict the full sample’s characteristics on the main demographic, 
predictor, and outcome variables in the study. Third, three multiple standard regression 
analyses were performed to assess the three separate study sub-hypotheses, as described 
ahead. Frequency tables and visual scanning indicated that data for all variables were 
entered accurately at each prospective data collection point.  
Missing and miscoded data. Frequency tables and visual scanning revealed no 
missing data in self-reported information by participants and minimal missing data in the 
data abstracted from medical records. As anticipated, the likelihood of substantial 
missing data was very low given the combined use of few, short self-reported instruments 
with chart abstraction strategies, and data collection undertaken in a comfortable and 
engaging clinic setting for this population of highly vulnerable pregnant women. 
Participants were cautioned during the consenting process to alert the PI if any item asked 
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in the interview created discomfort for them, but no pattern of missing values emerged 
suggesting that participants perceived some items as unusually sensitive. On the contrary, 
they seemed to welcome the opportunity to talk about their affiliation with their unborn 
children, their health practices during pregnancy, and their sometimes unfortunate social, 
personal, and economic circumstances.  
Most of the missing data related to information abstracted from the maternal 
medical records of participants who delivered during the study period. These absences 
reflected unknown or unreported information by the PRIM health practitioners. However, 
this unknown or unreported data referred to variables not included in the main analyses of 
this study, except for the outcome variable that measured the “last HIV viral load before 
delivery (medication adherence).” Inspection of all data corresponding to the 49 infants 
who completed the screening protocol showed no missing values.  
Descriptive statistics showed one missing and two miscoded values in the 
medication adherence measured in actual viral load amount and the classification of   
actual viral load amounts into categories of medication adherence, respectively. The latter 
entries were corrected after examining the original data collected from the participants’ 
records.  The single missing value in the medication adherence variable belonged to PID 
65, who attended her first prenatal care visit at 37 weeks gestation and delivered the next 
day. The routine last viral load before delivery was unknown to the health providers, as 
they could not order it from the lab due to lack of time. This case was excluded from the 
statistical analyses of this outcome variable (n=64).  
Descriptive statistics. Demographic and clinical variables, continuous and 
categorical, were organized in three types: socio-demographic, pregnancy-related, and 
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HIV-related. Preliminary analysis included the calculation of mean scores, standard 
deviation, skewness, and kurtosis of continuous demographic, predictor, and outcome 
variables to characterize the entire sample. Frequencies and percentages were tabulated 
for demographic categorical variables to observe the main tendencies for the entire 
sample. The assumptions of standard multiple regressions were tested using Pearson 
correlations, collinearity diagnostics, residuals analyses, and other necessary statistical 
procedures.  
Standard multiple regressions. Third, three multivariate analyses were 
performed to assess the each study sub-hypotheses. A standard multiple regression 
analysis examined a maternal-fetal attachment model and the unique independent 
contribution of MFA scores, history of drug use, marital partner status, planned 
pregnancy status, and timing of HIV diagnosis in predicting three continuous outcome 
variables: (1) HPQ-II scores measuring pregnancy care health behaviors, (2) HIV-1 viral 
load values measuring adherence to antiretroviral therapy (ART) during pregnancy, and 
(3) total number of postnatal screening visits by mother-and-child to the pediatric HIV 
clinic visits for infant care.  
This method assessed how much variance in each outcome variable is explained 
by the block of five hypothesized predictors. It also estimated the unique predictive 
power of each predictor variable, as if each entered the equation last. Standard rather than 
sequential multiple regression was selected because the study hypothesis does not specify 
a predetermined order of entry in the equation to control for the predictors entered first. 
Finally, stepwise regression is more appropriate for studies, unlike this one, aiming to 
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build a model rather than test a model by removing or including predictors from the 
model “under construction” based solely on statistical criteria (Pallant, 2010). 
Summary. This study was designed to test, as conceptualized from a strength 
approach and a socio-ecological framework, whether a relationship exists between the 
construct of maternal-fetal attachment and specific health behaviors of women living 
with HIV/AIDS during the period surrounding childbirth. A total of 82 women were 
recruited into the study, and data were collected from interviews with 76 of these women, 
and abstractions of maternal and newborn infants’ medical records. Relevant health 
behaviors of these participants were prospectively assessed at three time periods: 24 
weeks gestation, childbirth, and 16 weeks after childbirth. Participation in this study 
varied from 16 to 32 weeks. Strategies for data analyses included: (a) description of 
participants’ socio-demographic, pregnancy- and HIV-related characteristics; (b) 
examination of the distributions of participants’ scores on a maternal-fetal attachment 
scale, and on variables measuring their health behaviors; (c) examination of bivariate 
correlations between predictors and outcome variables; and (d) multiple standard 
regression analyses to examine the predictive power of a model of maternal-fetal 
attachment on three perinatal health behaviors, and to determine the unique contribution 
of each predictor to each health behaviors in the model. Results of these analyses are 
presented in the next chapter.  
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CHAPTER IV: RESULTS 
   
Descriptive Statistics 
 Socio-demographics. A sample of 82 pregnant women with HIV/AIDS was 
enrolled in the study over a 17-month period (July 2012- November 2013). One woman 
miscarried soon after enrolling, one tested negative in the HIV-1 RNA test performed 
around mid-pregnancy (considered a false-positive case), and four did not complete study 
measures because their gestational age was under 24 weeks by November 2013 (Figure 
1). Table 1 presents the socio-demographic characteristics of the remaining 76 study 
 participants. These were mostly Black or African American (67%) and Hispanic (34%), 
single (92%) and poor (88%). Regardless of marital status, over half (60.5 %) reported 
not living with their marital partner, and over third (37%) disclosed a history of using 
cigarettes, alcohol, marihuana and/or cocaine. Almost half of the participants (45%) had a 
High School or General Equivalency (GED) diploma. Maternal age at childbirth ranged 
from 17 to 43 years old (M = 27.7, SD = 6.19). 
Pregnancy-related characteristics. Table 2 displays the pregnancy-related 
clinical characteristics of the study group. The majority of participants (68%) reported 
not planning this pregnancy, and over half (54%) of these women reported no attempts at 
prevention. Most women (74%) reported two or more previous pregnancies, and 82% one 
or more live births. Over a third (37%) and more than half (54%) began prenatal care in 
the first and the second trimester, respectively. They attended between 1 and 16 prenatal 
visits to monitor the pregnancy and HIV disease (M = 9.5, SD = 3.29). Sixty five 
participants delivered during the study enrollment period, vaginally (32%) or by cesarean  
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Table 1 
Sociodemographic Characteristics of the Sample (n=76) 
 Frequency  
Variable N % M SD Median Range 
Age at delivery in years       27.7 6.19 27 17-43 
   ≤  27  34 52     
    28 or more 31 48     
    Pending delivery 
 
11      
Race       
   African-American         42 55     
   Haitian-American 6 8     
   Caribbean-American  3 4     
   White 
 
25 33     
Ethnicity       
    Hispanic 26 34     
    Non-Hispanic 
 
50 66     
Education       
    No HS diploma  24 31     
    HS/GED 34 45     
    Some college/degree     
         
18 24     
Income per year        
    Less than $10,000 67 88     
    $10,000-$30,000 6 8     
    More than $30,000 
 
3 4     
Housing       
    Own or rent 43 57     
    Stay with relatives  
        or friends 29 38   
  
    Homeless/shelter 
 
4 5     
Living with a partner 30 39.5     
Not living with a partner   
 
46 60.5     
Problem w/ partner 
No problem w/ partner 
 
Hx of substance use 
12 
63 
 
28 
16 
84 
 
37 
  
  
No Hx of substance use     48 63     
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Table 2 
Pregnancy-related Characteristics of the Sample  
 
 Frequencies  
Variable N % M SD Range 
Planned pregnancy 24 32    
Unplanned pregnancy 
     
52 68    
Previous pregnancies   2.61 1.81 0-9 
    None     9 12    
    One   11 14    
    Two or more 
 
56 74    
 Number of Children    1.74 1.57 0-8 
     None 14 18    
     One 24 32    
     Two or more 
 
38 50    
Entry to prenatal care   16.8 7.3 7-37 
    First trimester   24 37    
    Second trimester 35 54    
    Third trimester 6 9    
          
Total prenatal care visits 
 
  9.54 3.29 1-16 
Gestational Age at delivery     37.35 1.58 32-40 
    Premature 12 18    
    Full term 
 
53 82    
Delivery Type      
    C section 44 68    
    Vaginal 
 
21 32    
Birth weight < 2500 grams 11 17    
Birth weight > 2500 grams 54 83    
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section (68%). Only 18% infants were born preterm and 17% classified as having low 
birth weight. Only one (1.5 %) out of the 65 participants who gave birth transmitted HIV 
to her infant. Fifty four of the 65 HIV-exposed infants were scheduled to complete the 
16-week post birth screening protocol during the study enrollment and data collection 
period; however, one infant died of cardiac arrest 13 days after birth (Figure 1).  
HIV-related characteristics.  Most participants (80%) were diagnosed with HIV 
before this pregnancy, including four who acquired HIV perinatally from their mothers.  
The majority (69%) had an undetectable last viral load count (< 20 or <50) before 
delivery. About half of the women in this sample have lived with HIV for more than four 
and a half years, and only 11% were known to have AIDS (Table 3). They reported 0 to 
21 years since HIV diagnosis (M = 5.59, SD = 5.11). Slightly over three fourths of the 
infants (77 %) were brought by their mothers to three (32%) or all four (45%) of the 
scheduled screening clinic visits. Additional HIV-related clinical characteristics for the 
total sample are presented in Table 3.    
Reliability of study instruments. Eleven of the 76 protocols administered in this 
study used the Spanish version of the Maternal-Fetal Attachment Scale (MFAS) and the 
Health Practices Questionnaire (HPQ-II) developed by Ahern & Ruland (2003) and 
Lindgren (2005), respectively. First, Cronbach’s alpha was calculated for each of these 
scales to assess reliability of the total scales in measuring maternal-fetal attachment and 
health behaviors during pregnancy, respectively, in this study. Second, separate reliability 
was assessed for the English and Spanish version of each instrument to explore possible 
changes in comparison to the total reliability. Finally, reliability of each MFAS subscale  
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Table 3 
HIV-related Characteristics of the Sample  
 Frequency   
Variable N % M SD Range 
Last HIV VL before delivery      
   Detectable 20 31    
   Undetectable   
        
44 69    
Last CD4 count before 
delivery 
 
  
506.36 294.38 3-1374 
Last CD4 % before delivery 
 
  28 10.66 1-49 
Pregnancies after HIV Dx   .92 .92 0-5 
    None 22 35    
    One 28 44    
    Two or more 
 
13 21    
Timing of HIV Dx      
    Before pregnancy 61 80    
    During pregnancy  
  
15 20    
HIV disease stage          
    Not AIDS 54 83    
    AIDS     7 11    
    Unknown 
 
4 6    
Resistance test    23 35    
No resistance test   31 48    
Unknown 
    
11 17    
 Years since HIV diagnosis   5.6 5.12 0-21 
    ≤  4.5 32 50.7    
    More than 4.5 
 
31 49    
Total infant screening visits      
    None 1 2    
    One 2 4    
    Two 9 17    
    Three 17 32    
    Four 24 45    
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was calculated for comparison with previous research on the subscale structure of this 
instrument (Muller & Ferketich, 1993).  
 The internal consistency of the MFAS in this study was .84, probably indicating 
good reliability for this instrument. This Cronbach’s alpha value for the total scale 
concurs with previous reports in the literature (Lindgren, 2005; Muller & Ferketich, 
1993; Van den Bergh & Simons, 2009). Nineteen of the 24 items in the MFAS related 
very well to the total scale, correlation values ranged between r = .32 and r = .66. Four 
items (i.e., number 10, 13, 22, and 24) related to maternal perception of her body, naming  
the child and grabbing the fetus foot showed low correlations to the total scale, r ≤  .19. 
The retention of three of these four items (number 10, 13, and 24) should be revised 
because their deletion from the scale would have improved the internal consistency of 
this instrument, in this application. The reliability coefficient for the 20-item HPQ-II used 
in this study was .66, which indicates acceptable internal consistency for this instrument. 
However, this Cronbach’s alpha value falls below those reported in the literature (. 81, 
and .74; Lindgren, 2001, 2005). In this study, the abbreviation of this scale from 34 to 20 
items, and the inclusion of 10 reversed scored items may have lowered the reliability of 
this instrument. Six items (i.e., life style, sleep, food labels, prenatal visits, missed 
appointments, and support from friends or family) showed correlations over .30 to the 
total scale. Seven items (i.e., caffeine, marijuana, cigarettes, alcohol, prenatal care entry, 
weight, and childbirth classes) showed correlations of .15 or less to the total scale.  In this 
application, the deletion of those items inquiring about weight gain and intention to enroll 
in childbirth classes from the abbreviated HPQ-II scale would slightly improve the 
reliability of this instrument. 
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 In this study, the internal consistency reliability of the English and the Spanish 
language versions of the MFAS was .844 and .782, the former slightly higher and the 
latter slightly lower than the alpha coefficient calculated for both combined (. 837).  The 
internal consistency reliability for the abbreviated HPQ-II in the English (n = 65) and 
Spanish (n = 11) language used in this study were .650 and .618, respectively. Both of 
these values fell below the alpha coefficient calculated for the English and Spanish 
versions of this instrument combined (.66). The analysis of Chronbach’s alpha 
coefficients of internal consistency performed on the five subscales of the MFAS 
revealed that the most reliable subscales were those measuring maternal role taking (.79) 
and attributing characteristics and intentions to the fetus (.71). The least reliable subscale 
was the one measuring differentiation of self from the fetus (-.13).          
Analyses of main study variables. Means, standard deviations, skewness and 
kurtosis for maternal-fetal attachment total scores and variables measuring the health 
behaviors practiced by study participants are shown in Table 4. This analysis includes the 
absolute number, (log of) copies of viral RNA (“viral loads”), the original and the 
recoded total infant screening visits variables. The (log of) and recoded variables were 
introduced after data screening and preliminary analyses procedures. The rationale and 
procedures leading to the new two variables are explained ahead. The mean for maternal-
fetal attachment ( M = 90.37) is comparable to the means reported by Lindgren (2001) in 
a study with predominately White, highly educated, married women; and Ahner (2003) in 
a pilot study with a small subgroup of High School educated, and single African-
American women (M = 90.62 and M = 89.7, and SD = 10.99 and 13.9, respectively). In 
contrast, the mean for MFA from this study is higher than the means reported by Ethier et  
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Table 4 
Descriptive Statistics of Main Study Variables 
Variable N Mean SD Range Skewness Kurtosis 
Maternal-fetal 
Attachment 76 90.37 10.40 64-112 -.04 -.51 
Pregnancy health 
behaviors 76 82.99 7.07 58-95 -.93 1.25 
ART medication 
adherence (viral load) 64 2102 10327 20-68351 5.71 32.94 
ART medication 
adherence (log) (viral 
load) 
 
62 1.54 .95 1.02-4.83 1.98 3.32 
Total infant screening 
visits 
 
53 2.75 1.31 0-4 -.846 -.388 
Total infant screening 
visits (recoded) 53 3.15 .969 0-4 -1.105 .978 
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al. (2002) in a large multisite sample of HIV-infected ethnically minority women with 
low levels of education and income (M = 53, SD not reported). The use of a modified 
shorter version of HPQII scale prevents comparisons of the mean assessed in this study 
with previous research studies. The percentage of self-reported complete or optimal 
adherence to ART (69 %) by the participants in this study is higher than the percentage 
reported by Mellins et al. (2008) from a large group of women (61%) similar to the 
sample from this study, and lower than Nechega et al. (2012) findings (73.5%) in a meta-
analysis of studies reporting ART adherence rates during pregnancy.  The lack of studies 
in the research literature measuring health behaviors for infant care among HIV-infected 
mothers in the U.S. precludes comparison of the attendance rates found in this study to 
those in previous research findings. 
The procedure to code the maternal health behaviors for infant care variable was 
revised during data screening and preliminary analyses to account for those mothers who 
did not attend the screening clinic visits scheduled for their infants, but coordinated with 
the screening clinic nurse to have the indicated HIV PCR tests performed in a timely 
fashion by the infant’s pediatrician. The same applied for those premature infants whose 
mothers did not attend the screening clinic but the infants received the HIV PCR tests 
while inpatient in the neonatal intensive care unit. Thus, attendance to infant’s screening 
clinic visits or receipt of the HIV PCR test was counted on a ratio scale (0, 1, 2, 3, or 4 
attendances/test performed timely) and treated as a continuous variable. The recoded 
maternal health behaviors for infant care variable, TOTLVSTS_1 (recoded), replaced the 
original variable (TOTLVSTS).  
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Bivariate correlations between predictors and outcomes were calculated to further 
explore the study data set for unusual or anticipated correlations (Table 5). Maternal-fetal 
attachment strongly correlated with health behaviors for pregnancy care (r = .47). There 
was a medium strength positive correlation between planned pregnancy and optimal 
health behaviors for pregnancy care (r = .27). Finally there was a medium inverse 
correlation between history of substance use and (recoded) total postnatal infant care 
visits (r = -.29). The correlations among these variables follow the direction hypothesized 
in this study. 
Assumptions for Standard Multiple Regression Analysis.  
Sample size. The subsamples utilized for the regression analysis performed on 
each of the three outcome variables included 76, 65, and 53 cases for the health behaviors 
for pregnancy care, medication adherence and infant care, respectively. Data screening 
and preliminary analysis procedures conducted on the medication adherence variable, 
further reduced the size of the subsample computed in the regression analysis for the (log 
of) medication adherence variable to 62. None of these subsamples met the required 
sample size calculated a priori for a five-predictor multiple regression; however, the 
subsample for the pregnancy care variable met the criterion of 15 participants per 
predictor (15 x 5 = 75) typically recommended for social science research (Pallant, 2010). 
Whereas the lack of random sampling of participants in this study aggravates the 
violation of this assumption, it also reiterates the design of a hypothesis-testing study, 
such as this one, which aims to examine effect sizes in the data at hand, rather than 
relative values of population parameters (Hunter & May, 1993).   
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Table 5 
Bivariate Correlations Between Predictor and Outcome Variables 
Variable TOTALHPQ TOTLVSTS 
TOTLVSTS
(recoded) 
HIVVLIII 
(log) 
HIVVL_III 
MFATOTAL      .47** .16 .13 -.07 -.01 
LIVING -.21 -.13 -.14 -.06 -.14 
PLANNED    .27* .07 .09 -.22 -.12 
DRUGS  -.19 -.24 -.29* -.01 -.12 
MATHIV  .07 .17 .07 .08 .12 
HIVVLIII(log)  -.31*  -.43** -.31** 1 – 
HIVVL_III -.18 -.20 .15 .67** 1 
TOTLVSTS .25 1 .62** _ _ 
TOTLVSTS 
(recode) 
.04 _ 1 _ _ 
 
Note. All correlations are 2-tailed 
*p  <  .05. **  p  <  .01.  
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Multicollinearity. Bivariate correlation analyses among predictor variables were 
used to assess this assumption. The highest bivariate correlation among predictor 
variables was .213, and none reached significance level (Table 6). The repeated 
default values for collinearity statistics (Tolerance below .1 and VIF above 10) in each of 
the regression analyses conducted in this study (Tables 8, 10, and 12 ahead) further 
confirmed the lack of  collinearity among predictors.  
Univariate Outliers.  Frequencies, distributions and plots of ungrouped data were 
inspected to detect univariate outliers (Tabachnick & Fidell, 2001). Outliers and extreme 
outliers were identified in the box plots for the variables measuring total scores for the 
Health Practices Questionnaire or HIV viral load before delivery. None of the identified 
outliers resulted from data entry mistakes. The cases corresponding to the three univariate 
outliers observed in each of the boxplots for the pregnancy care and the infant care 
(recoded) variables were retained in subsequent analyses after evaluation of other 
indicators of normality in the distribution of these variables. However, the multiple 
extreme outliers observed in the distribution of the medication adherence variable 
seriously violated the assumption of normality for this variable. Thus, the appropriateness 
of data transformation strategies for that variable is described next.   
 Normality in the distribution of variables. Skewness and kurtosis analyses were 
performed to further examine the distributional properties of predictor and outcome 
variables in preparation for regression analyses (Table 4). A kurtosis less than the 
absolute value of 2 indicated normal distribution for the variables measuring maternal-
fetal attachment (MFATOTAL), health practices during pregnancy (TOTALHPQ) , and 
attendance to the postnatal screening clinic visits for their infants (TOTLVSTS_1). In   
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Table 6 
 Bivariate Correlations Among Predictors  
Variable MFATOTAL LIVING PLANNED DRUGS MATHIV 
MFATOTAL 1     
LIVING .213 1    
PLANNED .063 -.027 1   
DRUGS -.125 .109 .009 1  
MATHIV .014 .005 .161 .101 1 
 
addition, the negatively skewed distribution of these variables showed that most women 
in this study reported being strongly attached to their unborn children, frequently 
practicing prescribed health behaviors during pregnancy, and were observed to attend or 
performed the corresponding lab for 3 or 4 of the scheduled postnatal screening visits for 
their infants. The examination of histograms and Normal Q-Q plots for these variables 
revealed a fairly normal distribution for the MFATOTAL variable and only some 
deviations from normality for the TOTALHPQ and the TOTLVSTS (recoded) variables. 
Finally, a positive kurtosis indicated a peaked distribution for the TOTALHPQ and the 
TOTLVSTS (recoded) variables.     
In contrast, a positive kurtosis much greater than 2 (32.94) revealed severe 
deviation from normality, and clear peakedness in the distribution of the variable 
measuring medication adherence (HIVVL_III or the last viral load before delivery). This 
distribution was positively skewed, showing most women attained perfect adherence and 
virologic response to ART (i.e., low viral load values in the undetectable range). This 
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pattern of distribution is commonly observed by medical researchers who use quantitative 
HIV viral loads values to assess efficacy of ART (Farzadegan et al., 1998; Moulton, 
Curriero, & Barroso, 2002). As a result, these researchers have used the logarithm with 
base 10 strategy to transform the HIV-1 viral load values and satisfy the assumption of 
normality for parametric tests. The Log10 transformation strategy makes statistical and 
clinical sense when applied to viral load values. Statistically, Log10 transformation makes 
sense because it pulls in extreme ranged values more drastically than other lower bases. It 
also transforms positive skewed distributions by effectively compressing the right side of 
the distribution (Osborne, 2002). This application makes practical sense in clinical and 
possibly data interpretation because log transformed HIV viral load values are already 
routinely used in monitoring and comparing significant changes in viral load to assess 
treatment efficacy (e.g., 1.0 log viral load reduction is expected after perfect adherence to 
antiretroviral therapy for 8 weeks, Cobb, Vaks, Do, & Vilchez, 2011; Kalichman, 
Rompa, & Cage, 2000). This variable was transformed before searching for any 
multivariable outliers in its distribution. 
This study employed the specific Log10 transformation recommended by 
Farzadegan et al. (1998) in preparation for regression analyses as follows: (a) lower 
detection limit was identified (21) and half of its value was calculated (10.5), (b) 10.5 
replaced all undetectable values abstracted from the medical records, and (c) the 
recalculated viral load values were then log10 transformed. However, two out of the 64 
cases at data point 2 were excluded from this transformation procedure because the HIV 
viral load assays used in these cases had different sensitivities for detection and 
quantification of the HIV viral load (< 50 v. < 20 copies m/L; Cobbs et al., 2011). Instead 
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of arbitrarily altering the viral load value abstracted from the medical record, these cases 
appeared as missing from this procedure (n = 62).    
The application of the log10 transformation procedure reduced skewness from 
5.71 to 1.98 and kurtosis from 32.94 to 3.32 for the log_HIVVL3 variable; and visibly 
improved normality in the distribution of the new variable compared to the original, as 
displayed in the SPSS-generated histograms and plots (Tabachnick & Fidell, 2001). The 
number of extreme univariate outliers was reduced compared to the original 
untransformed distribution (Tabachnick & Fidell). The moderate correlation between the 
original and the new “viral load” medication adherence variable and weak correlations 
between the transformed and the predictor variables pointed to the appropriateness of this 
data transformation process (Table 5; Heppner & Heppner, 2004). Thus, the (log of) 
medication adherence variable replaced the original viral load medication adherence 
variable in subsequent statistical analyses.  
Multivariate outliers. The 62 cases, with transformation applied to the (log of) 
viral load variable, were screened for multivariate outliers through regression using the 
Malahonis distance analysis, and two other study variables (i.e., MFA scores, and 
pregnancy care). In this analysis, all 62 cases showed Mahal distance under the critical 
value criterion (critical χ 2 at α  = .001 for 3 df is 16.27; Pallant, 2010).  The identified 
extreme univariate outliers remaining after transformation were not multivariate outliers; 
they were probably a proper part of the sampled population (Tabachnick & Fidell, 2001). 
They are still on the tail of the transformed distribution; however, their influence has 
probably been reduced by the transformation. Then, all 62 cases were retained for 
analysis of the transformed variable because no multivariate outliers were identified in 
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the preliminary analysis (Tabachnick & Fidell).  The 53 cases in the distribution of the 
infant care variable (recoded) were screened for multivariate outliers through regression 
using the Malahonis distance analysis, and three other study variables –i.e., MFA scores, 
(log of) medication adherence, and pregnancy care. In this analysis, only one case (PID 
36 = 18.48) is very slightly outside the Mahal distance value criterion (critical χ 2 at α  = 
.001 for 4 df is 18.47; Pallant, 2010). This case was retained in the analysis of the health 
behavior for infant care variable. 
Primary Analyses  
All three standard regressions tested the same model as stated in the study 
hypothesis, and all independent variables were entered into the equation simultaneously. 
A separate regression analysis was conducted for each of the three dependent or outcome 
variables. All primary analyses tested the main study hypothesis using SPSS 
REGRESSION and evaluated assumptions using SPSS FREQUENCIES.  
 Pregnancy care. A standard multiple regression was performed between health 
behaviors for pregnancy care (TOTALHPQ), as the outcome variable and maternal-fetal  
attachment (MFATOTAL), living marital status (LIVING), planned pregnancy status 
(PLANNED), history of substance use (DRUGS) and timing of HIV diagnosis 
(MATHIV) as  the predictor variables. This study hypothesized that these five 
independents variables will predict health behaviors for pregnancy care, the first outcome 
variable of the study hypothesis. The standard regression analysis assessed the predictive 
ability of the hypothesized model and the unique contribution of each predictor.  
The assumptions in this regression analysis were evaluated using the criteria 
recommended by Tabachnick and Fidell (2001). The plot of the distribution of residuals 
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suggested no major violations of normality. Outliers were evaluated using the Mahalonis 
distance (critical χ 2 at α  = .001 for 5 df is 20.52), and no outliers were identified. The 
model in this solution missed to predict the health behaviors for one case (PID 65); 
however, its corresponding value for the Cook’s distance statistic indicated that this case 
was not unduly influencing the results for the model as a whole. All the predictors show 
some relationship with the health behaviors for pregnancy care variable, and three of 
these correlations reach statistical significance (Table 7). The highest correlation among 
them was .469. Maternal-fetal attachment and planned pregnancy status correlate  
Table 7 
Correlation Matrix for the predictors of Pregnancy Care  
*p < .05. ** p < .01. *** p < .001.  
 
substantially with maternal health behaviors for pregnancy care (.47 and .27, 
respectively). Further, all variables entered the equation without violating the default 
value for tolerance and VIF (Tolerance ≥  .93 and VIF  ≤  1.08).  
Variable 1 2 3 4 5 6 
1 Pregnancy care –      
2 Maternal-fetal Attachment .47*** –     
3 Living marital status -.19 .21* –    
4 Planned pregnancy .27** .06 -.03 –   
5 History of Substance Use -.19* -.13 .11 .01 –  
6 Timing of HIV Diagnosis .07 .01 .01 .16 .10 – 
63 
 
The independent variables (MFATOTAL, LIVING, PLANNED, DRUGS, and 
MATHIV) were entered simultaneous into a regression model predicting health behaviors 
for pregnancy care (TOTALHPQ). The results displayed in Table 8 indicated that the 
predictors explained 37% of the variance in maternal health behaviors for pregnancy care 
(R2 = .37). Maternal-fetal attachment, living marital status and planned pregnancy status 
were found to be significant predictors of health behaviors for pregnancy care. Maternal-
fetal attachment made the largest unique contribution (β  = .50), followed by living 
marital status (β  = -.275), and planned pregnancy status (β  = .227).  Maternal-fetal 
attachment and planned pregnancy status are positively related to health behaviors for 
pregnancy care, whereas living marital status has an inverse relationship with this 
maternal health behavior. The regression model supports the research hypothesis that 
maternal-fetal attachment, history of drug use, marital relationship status, planned 
pregnancy status, and timing of HIV diagnosis will independently predict pregnancy care 
among women living with HIV/AIDS. For this outcome variable, the null hypothesis is 
rejected in favor of the alternative hypothesis. 
 ART adherence. A standard multiple regression was used to assess the ability of 
maternal-fetal attachment (MFATOTAL), living marital status (LIVING), planned 
pregnancy status (PLANNED), history of substance use (DRUGS) and timing of HIV 
diagnosis (MATHIV) to predict the health behavior of ART adherence during pregnancy 
(HIVVL_III). This study hypothesized these five independents variables will predict 
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Table 8 
Predictors of Health Behaviors for Pregnancy Care 
Variable Pregnancy Care 
B SE B β  t  
Maternal-fetal Attachment 0.34 0.07 0.50  5.07*** 
Living marital status -3.96 1.41 -0.28 -2.81** 
Planned pregnancy status 3.44 1.46 0.23  2.36* 
History of Substance Use -1.55 1.41 -0.11 -1.09 
Timing of HIV Diagnosis 0.62 1.71 0.04  0.37 
     
R2 = .370      
Adjusted R2 = .325     
F = 8.226 ***     
Note. N = 76 
 
* p < .05. ** p < .01. *** p < .001.  
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ART adherence—the second outcome variable of the study hypothesis—during 
pregnancy and each will contribute uniquely to this prediction.   
The evaluation of assumptions prior to this analysis led to the transformation of 
the original outcome variable (HIVVL_III) into a new ART medication adherence and 
virologic response variable (log_HIVVL3), which effectively reduced skewness and 
kurtosis, and improved the fit between the distribution of this variable and the 
assumptions of multivariate regression analysis. The criteria recommended by 
Tabachnick and Fidell (2001) were used to evaluate assumptions in the regression 
analysis of the (log of) viral load (ART adherence) variable. The histogram for (log of) 
viral load (ART adherence) improved further into a normal distribution when assessed in 
the regression analysis. The residuals scatterplot approximated a rectangular shape and 
the normal probability plot moved towards the diagonal line, both suggested no major 
violations of normality. In addition, the value for Durbin-Watson statistics (2.1) 
calculated in this regression analysis further indicated the non-correlation of residuals. 
None of the cases had a value in excess of the Mahalonis distance critical value (critical 
χ 2 at α  = .001 for 5 df is 20.52); therefore, no multivariate outliers were identified in 
this regression analysis. The hypothesized model in this solution missed to predict the 
medication adherence measure for one case (PID 55); however, the maximum value for 
the observed Cook’s distance statistic indicated this case did not unduly influence the 
results for the model as a whole (Pallant, 2010). All the predictors show weak 
relationship with the (log of) viral load (ART adherence) variable, the highest correlation 
among them was .22. Nevertheless two of these correlations reached statistical 
significance (Table 9). All variables entered the equation without violating the default  
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Table 9 
Correlation Matrix for Predictors of (log of) viral load (ART Adherence)   
 
*p < .05.  
 
 
 
 
 
 
 
 
 
 
 
 
Variable 1 2 3 4 5 6 
1 Medication Adherence –      
2 Maternal-fetal Attachment -.07 –     
3 Marital partner status -.06 .23* –    
4 Planned pregnancy status -.22* -.07 .04 –   
5 History of Substance Use -.01 -.01 .13 .05 –  
6 Timing of HIV Diagnosis .08 .03 -.03 .12 .12 – 
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value for tolerance and VIF (Tolerance ≥  .93 and VIF  ≤  1.08), further indicating 
absence of multicollinearity among the variables.  
As shown in Table 10, the model tested in this regression analysis failed to predict 
(log of) viral load (ART adherence); however it revealed a medium effect size in the 
association between the maternal-fetal attachment model and this measure of ART 
adherence (R2 = .067). The regression model was not consistent with the research 
hypothesis that maternal-fetal attachment, history of substance use, marital relationship 
status, planned pregnancy status, and timing of HIV diagnosis will independently predict 
undetectable viral load among pregnant women living with HIV/AIDS. Thus, the null 
hypothesis cannot be rejected for the second outcome variable.  
Total infant screening clinic visits. A standard regression tested the alternative 
hypothesis that maternal-fetal attachment (MFATOTAL), living marital status (LIVING), 
planned pregnancy status (PLANNED), history of substance use (DRUGS) and timing of 
HIV diagnosis (MATHIV) will predict the health behavior of attendance to the infant 
HIV screening clinic visits after birth (TOTLVSTS_1).  This maternal health behavior is 
the third outcome variable of the study hypothesis.   
 The evaluation of assumptions in this regression analysis used the criteria 
recommended by Tabachnick and Fidell (2001) and results revealed no cause for 
concern. The plot of the distribution of residuals suggested no major violations of 
normality. Outliers were evaluated using the Mahalonis distance (critical χ 2 at α  = .001 
for 5 df is 20.52), and no outliers exerted undue influence in the results of this analysis. 
All the predictors show some relationship with the TOTALVSTS_1 variable, and the  
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Table 10 
Predictors of Health Behaviors for (log of) viral load (ART Adherence) 
Variable (log of) Medication Adherence 
B SE B β  t  
Maternal-fetal Attachment -.007 .012 -.076 -.568 
Marital partner status -.047 .255 -.025 -.184 
Planned pregnancy status -.497 .276 -.236 -.1.80 
History of Substance Use -.010 .256 -.005 -.040 
Timing of HIV Diagnosis .277 .336 .108 .825 
     
R2 = .067      
Adjusted R2 = -.017     
F = .801     
Note. N = 62 
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correlation between history of substance use and this outcome variable revealed a small 
to medium inverse correlation (Table 11; r = -.29). This correlation was also the highest 
one among predictors in this regression analysis. Further, the presence of 
multicollinearity was ruled out because all variables entered the equation without 
violating the default value for tolerance and VIF (Tolerance ≥  .91 and VIF  ≤  1.1).  
As shown in Table 12, the model tested in this regression failed to predict 
attendance to the screening visits for infant care; however this relationship showed a 
medium to large effect size (R2 = .128). The regression model was not consistent with the 
research hypothesis that maternal-fetal attachment, history of drug use, marital partner 
status, planned pregnancy status, and timing of HIV diagnosis will independently predict 
postnatal infant care among pregnant women living with HIV/AIDS. Thus, the null 
hypothesis cannot be rejected for the third outcome variable. 
Exploratory analyses  
A last set of post-hoc analyses explored correlations on the outcome variables 
across selected descriptive variables, beyond the initial hypothesis.  Given the mixed 
results in the main analyses, these analyses aimed to identify hints for potential analyses 
in future studies. In addition, it explored differences between Hispanic and non Hispanic 
participants among predictor and outcome variables. Exploratory findings are presented 
in Tables 13, 14, and 15. The findings of post-hoc analyses are discussed in Chapter VI.  
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Table 11  
Correlation Matrix for Predictors of Attendance/Test to Postnatal Care Visits   
*p < .05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable 1 2 3 4 5 6 
1 Total infant care visits –      
2 Maternal-fetal Attachment .13 –     
3 Marital partner status -.14 .14 –    
4 Planned pregnancy status .09 -.06 .03 –   
5 History of Substance Use -.29* -.13 .18 .10 –  
6 Timing of HIV Diagnosis .07 -.01 .02 .14 .18 – 
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Table 12 
Predictors of Health Behaviors for Postnatal Care Visits   
Variable Attendance to Infant Care Visits 
B SE B β  t  
Maternal-fetal attachment .012 .01 .12 .87 
Marital partner status -.21 .27 -.11 -.78 
Planned pregnancy .26 .31 .12 .84 
History of Substance Use -.55 .28 -.28 -1.96 
Timing of HIV Diagnosis .27 .33 .11 .80 
     
R2 = .128     
Adjusted R2 = .035      
F = 1.38     
Note. N = 53 
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Table 13 
Correlations between outcome and other selected variables 
Variable 1 2 3 4 5 6 7 8 9 
1 Pregnancy 
Care 
–         
2 (Log) Med 
Adherence 
-.31* –        
3 Total 
Infant Visits 
.22 -.31* –       
4 Ethnicity .20 -.34** .13 –      
5 PNC Entry -.14 .42** -.14 -.06 –     
6 MFA .47** -.07 .13 .09 -.22 –    
7 Stage of 
HIV disease 
-.23 .01 -.03 .04 .26* -.05 –   
8 Years of 
Diagnosis 
-.11 .00 -.03 .02 -.27* -.01 -.08 –  
9 Total PNC 
visits 
.36** -.57** .18 .29* -.75** .31* -.32** .04 – 
Note. All correlations are 2-tailed 
*p  <  .05. **  p  <  .01.  
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Table 14 
Comparison of maternal-fetal attachment and outcome variables by ethnicity 
 Hispanic Non-Hispanic   
Variable M SD M SD t D 
Maternal-fetal attachment 91.69 9.7 89.68 10.8 .79 .19 
Pregnancy Care 84.92 6.1 81.98 7.4 1.74 .40 
Medication adherence 1.10 .33 1.77 1.09 -3.6*** -1.01 
Infant Care  3.32 .82 3.06 1.04 .92 .26 
 
 *** p = .001 
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Table 15 
Comparison of predictor variables by ethnicity 
Variable Hispanic % 
(n = 26) 
Non Hispanic % 
(n = 50) 
Total % 
(N = 76) 
χ 2 Phi 
Marital partner status 
      Yes 
      No 
 
 
50 (13) 
50 (13) 
34 (17) 
66 (33) 
 
39.5 (30) 
60.5 (46) 
1.83 .16 
Hx of substance use 
      Yes 
      No 
 
 
53.8 (14) 
46.2 (12) 
28 (14) 
72 (36) 
 
37 (28) 
63 (48) 
4.91* .25 
Timing of HIV dx 
      Before pregnancy 
      During pregnancy 
 
77 (20) 
23 (6) 
 
82 (41) 
18 (9) 
 
80 (61) 
20 (15) 
 
.28 .6 
Planned pregnancy status 
      Yes 
      No 
 
 
42 (11) 
58 (15) 
 
26 (13) 
74 (37) 
 
32 (24) 
68 (52) 
2.11 
 
.15 
*p < .05 
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CHAPTER V: LIMITATIONS  
This study contains important limitations and strengths. The key limitations are 
summarized in this section, and in the next chapter, some of them are discussed further in 
relation to the literature. The lack of random sampling of participants is an overarching 
limitation of this study; however, the choice of a non random sample may be appropriate 
given the population of interest and the theoretically conceived hypothesis of this study 
(Kam, Wilking, & Zechmeister, 2007). Therefore, the statistical analyses performed in 
this investigation aim to provide estimate of effect sizes rather than inferences of 
population parameters (Hunter & May, 1993; Smith M., 2009). The interpretation of  
findings discusses effect sizes rather than the statistical significance of the tests. Although 
participants were not randomly sampled, they represent 50% and 43% of the population 
of pregnant women in the PRIM clinic and Miami Dade County, respectively. 
Nonetheless, the potential biases in the sample investigated here are discussed ahead. 
The presence of social desirability bias in the administration of instruments 
assessing self-reported maternal-fetal attachment and health behaviors during pregnancy 
is another important limitation in this study. Given the high scores observed for most of 
the women in the scales measuring these variables, women may have responded as they 
thought it was socially expected of them. However, their actual maternal-fetal attachment 
or health behaviors may not conform to these responses to the interview questions. This 
discrepancy may have affected the measurement of these predictor or outcome, and could 
explain why the data would only partially support a reasonable study hypothesis of a 
prospective relationship between maternal-fetal attachment and maternal health behaviors 
for medication adherence and infant care.  
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The conflating of ART adherence and virologic response is another limitation of 
this study. Adherence to ART is a highly complex combination of behaviors, and 100% 
adherence (or >90%-95% doses consumed) is neither necessary nor sufficient to achieve 
an undetectable viral load, even when resistance to antiretroviral agents is excluded (C. 
Beck-Sague, personal communication, February 7, 2014). Undetectable viral load 
depends to a considerable degree on regimen (e.g., lopinavir/ritonavir containing 
regimens more often result in undetectable viral loads, and are far more “forgiving” of 
missed doses than nevirapine containing regimens) (C. Beck-Sague, personal 
communication, February 7, 2014). The operational definition of the medication 
adherence variable to only this one indirect measure, instead of studying and reporting 
the association of maternal-fetal attachment with pill-count adherence measures and 
maternal report (both of which could have given a more multifaceted and direct view of 
adherence), limits the ability to detect an association. 
The inclusion of only those pregnant women with HIV who attended the PRIM 
clinic, and the exclusion of those attendees who spoke only Creole may have excluded 
some potential participants of higher socioeconomic status or of various ethnic or racial 
background, especially Haitian-American. However, unexpectedly, the high mean MFA 
score found in this sample correspond more to findings from samples of uninfected 
pregnant women belonging to higher socioeconomic status, than to a multi-site sample of 
similar HIV infected pregnant women matched on demographic characteristics to their 
uninfected peers (Ethier et al. 2002; Lindgren, 2001). These inclusion and exclusion 
criteria may have added inaccuracies to the description of the HIV-infected pregnant 
women portrait in this sample.  
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 The subsamples used in the analyses attempting to predict pregnancy-related 
health behaviors, ART medication adherence, and attendance to postnatal infant care 
visits decreased in size across time from 76 at data point Time1 to 53 participants at data 
point Time 3. Whereas the lack of random sampling voids the issue of sample size related 
to adequate power, several actions were taken in this study to prevent sample attrition 
across the data collection points of this prospective study and assess effects under optimal 
circumstances (Hansen & Collins). Finally, a study, such as this one, focused on 
assessing effect sizes in a nonrandom small sample of pregnant women with HIV/AIDS 
may be valuable in the early stages of researching the association between maternal-fetal 
attachment and maternal health behaviors among these women (Kam et al., 2007; Slavin 
and Smith, 2009). 
Some of the study instruments or measures used in this study may not have been 
as valid or reliable as anticipated. Whereas the recoding of the variable measuring 
attendance to postnatal screening visits for infant care may have captured some of the 
nuances in measuring this maternal health behavior, the over-simplicity of this 
measurement counts among the limitations in this study. Whereas the total maternal-fetal 
attachment scale (MFAS) appeared reliable in this study, the dimensionality of maternal-
fetal attachment as conceptualized in the MFAS may need revision (Muller and 
Ferketich, 1993). The MFAS may include too many items related to the pregnancy state 
and the motherhood role instead of attachment to the fetus (Van den Bergh & Simons, 
2009). The composition of items in the MFAS could have diminished the ability of this 
instrument to actually measure relevant dimensions of maternal-fetal attachment among 
participants (Van den Bergh & Simons). The modified 20-item HPQ-II scale used in this 
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study to measure maternal health behaviors for pregnancy care showed less reliability 
than the full 34-item HPQ-II scale. Although the 20 items included in the shorter version 
were carefully selected based on reliability analyses conducted by Lindgren (2005) for 
the full HPQ-II scale, and cultural competency considerations; the abbreviated HPQ-II 
scale may need revision to improve its reliability for use in future research with women 
from diverse ethnic, racial and socio-economic backgrounds.   
Finally, the fact that a single investigator conducted all the stages of this 
prospective study and monitored the quality of its implementation may have created 
unrealistic conditions that could never be replicated on a large scale study. Slavin & 
Smith (2009) opines that this phenomenon of “superrealization” often affects the external 
validity of small studies, and may limit its reproducibility.  
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CHAPTER VI: DISCUSSION 
 This study was conducted in an effort to fill gaps in the existing literature 
regarding the examination of an association between a maternal-fetal attachment model 
and health behaviors and response to ART during pregnancy and childbirth among 
women living with HIV/AIDS. The integration of the developmental concept of 
maternal-fetal attachment to examine its role in predicting health behaviors from a 
strength-based and a socioecological perspective has not been explored in the relevant 
literature; therefore, results of this study offer a meaningful contribution to the 
knowledge base. Also, the understanding of a comprehensive socioecological maternal-
fetal attachment model with respect to the health behaviors of women with HIV/AIDS 
has begun to take shape. This understanding, alternative or complementary to the medical 
model, may open additional opportunities for assessment and intervention of health 
behaviors in these women. 
This chapter interprets and discusses the findings of this study. First, some general 
issues related to the recruitment, data gathering and the clinic setting of the present study 
are discussed aiming for transparency in the interpretation of findings and reproducibility 
of the analyses (Smith, 2009). Second, main descriptive findings are summarized and 
compared to previous research of pregnant women with HIV/AIDS or, in some instances, 
to normative populations in the U.S. Third, findings regarding the tri-fold research 
question are examined in light of the current HIV and maternal-fetal attachment research 
literature, and the contrast between a maternal-fetal attachment model and a prevalent 
medical model of prenatal and postnatal care, particularly in high risk pregnancies.  
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The Clinic Settings and the Recruitment Process 
The task of recruiting a sample of HIV-infected pregnant women and their 
newborns from the local obstetric and pediatric clinic population was at least as 
challenging as anticipated during the preparatory stages of this research study, even for a 
PI who is affiliated, directly or indirectly, to these clinics. The first challenge was the 
recruitment of participants from an already limited pool of potential eligible women to 
ascertain a large enough sample.  At the conclusion of the study, 110 (70%) of the 
approximately 157 women who attended the obstetric clinic from January 2012 to 
December 2013, were invited to participate because they met eligibility criteria, and 82 
(75%) of the 110 were recruited. These relatively high recruitment rates could be 
attributed to decisions by the PI to extend the recruitment process by 5 months and 
separate the consenting process from the actual enrollment in the study at 24 weeks or 
longer gestation. Despite the relatively high recruitment rates, it remains unknown how 
many of the 47 women who attended the PRIM clinic and were not invited to participate 
met eligibility criteria. Secondly, this study underestimated the refusal rate (25%, 28/110) 
among the invited potential participants. Although some of the 28 women expressed 
reasons for declining participation (Figure 1), the reasons for many of them remain 
unknown because they did not verbalize them. In interpreting the findings, it would have 
been helpful to know in what ways the women who declined participation differed from 
those who volunteered to participate, along descriptive and study variables 
characteristics. Third, in several occasions the PRIM clinic also functioned as an HIV 
counseling resource for women diagnosed with HIV during pregnancy. In these cases, the 
PI was asked to coordinate with the health practitioners and postpone recruitment until 
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confirmation of an HIV diagnosis through laboratory results. If unconfirmed, these 
women were ineligible for the study; if confirmed the recruitment may have been 
postponed even longer until the woman is properly counseled on her HIV diagnosis and 
all necessary medical or psychological procedures were completed. This additional step 
in the recruitment of women diagnosed with HIV during pregnancy may explain the 
unexpected low percentage of newly diagnosed participants in this study.       
Considering the exclusion criteria in this study, one could assume that most of the 
ineligible women only spoke Creole and were of a Haitian ethnic or cultural background. 
Whereas the inclusion of these women in this study could have described the sample of 
HIV-infected pregnant women more accurately, the added cultural and ethnic or disease 
trajectory heterogeneity to an already diverse sample could have reduced the effect size 
of some of the analyses performed in this study (Hansen & Collins, 1994). Some 
monolingual Haitian-American women may face similar and different life circumstances 
impacting the trajectory of their pregnancies and HIV disease than those faced by the 
African-American, Hispanic-American, and bilingual Haitian-American who participated 
in this study. For example, similar to Hispanic-American women, they may face language 
and immigration status barriers in accessing prenatal or HIV care on a timely basis.  
The reasons expressed by some women to decline participation and other relevant 
observations from the PI were logged in the study notebook. Were some of these women 
who declined study participation because of the low monetary incentive for participation 
of higher socio-economic status than those who participated? Others may have declined 
because they chose to keep private issues of substance use, investigation from child 
protection, domestic violence, or tentativeness or ambivalence about their pregnancy. 
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Had they been included in the study, would some or all of these issues possibly change 
the results reported here? Even the ethnicity of the PI may explain the low rate of decline 
participation among Hispanic-Americans compared to African- and Haitian-Americans. 
Finally, the differing clinic setting and the contrasting circumstances of the newly and 
previously diagnosed women may have precluded the recruitment of the newly diagnosed 
woman in favor of the previously diagnosed ones; possibly explaining a bias in this 
direction.  
During this study period, an estimated 53 infants were born to HIV-infected 
mothers in Miami Dade County who did not attend the PRIM clinic but received prenatal 
care somewhere else, or who did not receive prenatal care anywhere else 
(PRIM/Screening, 2013). These mothers also pose challenging questions in interpreting 
the findings in this study. One can only speculate that these women may belong to the 
two extremes of the socioeconomic status spectrum. On the one hand, some with higher 
incomes may have used private or public health insurance to access private obstetric 
clinics in their communities for prenatal care. On the other hand, some with lower 
incomes or simply uninsured women may have experienced these or other psychosocial 
barriers precluding access to any prenatal care. One can only wonder how else these 
women would have differed from the participants in this study on the measures taken to 
describe the sample or run the hypothesis-testing analyses; and how, if included, they 
would have changed the findings of this study.  
 Prior to interpreting the findings related to the maternal attendance to the 
screening clinic visits for infant care, the screening protocol process itself deserves some 
discussion. A mother who regularly brings her infant to the appointments scheduled in 
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the screening clinic for the prevention of HIV transmission demonstrates optimal 
maternal health behavior, even maternal caregiving. However, circumstances beyond her 
volition could have explained irregular or no-attendance at her infant’s HIV-related 
medical appointments (E. Santana, personal communication, December 31, 2013).  
Financial factors commonly reported by participants and recorded in the infant medical 
records included: (a) lack of health insurance coverage for the visit itself or the HIV PCR 
laboratory test for the infant; (b) delays in accessing health coverage for the infant; (c) 
conflicts in health insurance coverage between services provided by the regular 
pediatrician and the specialized HIV pediatric care; and (d) transportation to the clinic 
site. Other women reported adverse life circumstances that interfered with the time 
sensitive screening protocol including: (a) hospitalization or other medical complications 
involving mother or infant, (b) feared or actual intervention from child welfare 
authorities, (c) maternal drug-related foster care placement for the infant and (d) maternal 
incarceration. Other less tangible but equally troublesome factors that disrupted the 
maternal care of the women in this sample were lack of family support and the stigma 
related to a maternal HIV diagnosis. For example, some mothers coped with the 
perceived stigma by taking the infant to the screening clinic because they preferred to 
keep the HIV diagnosis private from the pediatrician or their own families. Other 
mothers, perhaps those with experience from a previous pregnancy, do not attend the 
scheduled screening clinic visits; however, they coordinated with the nurse from the 
screening clinic to complete the sequence of HIV PCR tests in a timely manner at the 
office of the regular pediatrician selected by or assigned to the mother. Finally certain 
mothers neither attend the scheduled screening visits nor coordinate for the pediatrician 
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to perform the tests; in these instances the screening clinic social worker calls the local 
child protection program to report the mother for medical neglect. Furthermore, some of 
the pediatricians practicing in the community refuse to perform or monitor the HIV 
screening protocol for their patients, and instead they prefer that these patients attend the 
screening clinic. An international qualitative study in Kenya analyzed the thematic 
content related to routinely taking children to HIV care (Wachira et al., 2013). They 
found that this decision involved multiple levels of intrapersonal, interpersonal, 
community and health system factors, which intertwined in complex ways to affect the 
decisions of Kenyan mothers to take their children to HIV care. Even considering the 
remarkable differences in cultural, socioeconomic and health care for HIV disease 
environments between the U.S. and Kenya, Wachira’s et al. (2013) findings resemble the 
psychosocial ecology of the HIV-infected mothers found in this sample. One might ask if 
this study’s measure of attendance to the screening visits assesses maternal health 
behaviors for infant care and captures the nuances of the experience faced by mothers 
living with HIV/AIDS. When assessing maternal health behaviors for infant care, the 
regular attendance of the infant’s screening clinic appointments, and the no-attendance 
but completion of the HIV tests on time elsewhere appear to be equivalent behaviors in 
demonstrating protective attachment to their infants (A. Garcia, personal communication, 
September 30, 2013). Any intervention aiming to reduce the frequency of incomplete 
screening protocols for HIV-exposed infants by promoting maternal health behaviors for 
infant care could benefit from including at least some of these multi-level factors 
(Wachira et al., 2013). 
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Characteristics of Pregnant Women with HIV/AIDS  
 When compared with findings from other similar samples of HIV-infected 
pregnant women studied in previous research, findings on the socio-demographic, 
pregnancy-, and HIV-related characteristics of this sample could be interpreted within the 
context of changes, or lack of changes, in the evolution of the HIV epidemic in the U.S. 
over the last 30 years. The critical review of these descriptive findings aims to provide an 
update about an under-researched group of women, at high risk for poor maternal health 
behaviors and disrupted mother-infant attachments.    
 Socio-demographic characteristics. The pregnant women in this study were 
low-income Black or African-American, or Hispanic in the peak of the childbearing 
years, living in metropolitan Miami. These demographics parallel the general population 
of HIV-infected women in the U.S. in 2010 (The Kaiser Family Foundation, 2013) and 
concur with the demographics reported in previous studies, even those dating back to the 
late 1980s, investigating ART adherence or quality of prenatal care in similar samples 
(Bardeguez et al., 2008; Ethier et al., 2002; Mellins et al., 2008 Turner et al., 1996). This 
finding is consistent with public health surveillance reports indicating a persistent 
disproportionate impact of HIV disease on minority women, compared to their 
representation in the overall population of females in U.S. census (Kates et al., 2013). In 
contrast, most of the participants in this study reported a higher educational level (i.e., 
High School or more) than HIV-infected pregnant women sampled in previous research 
studies (i.e., less than high school education; Cohn et al., 2008; Ethier et al., 2002). The 
findings regarding housing arrangements indicated a trend towards stability for the 
women in this study compared to descriptions on this demographic characteristic in 
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earlier research (Ethier et al. 2002). Unfortunately, the advantages in educational 
achievements and housing arrangements for the participants in this study did not appear 
to translate into higher socioeconomic status. Although outside of the scope of this study, 
the persistent health disparities in HIV disease incidence and access to health care comes 
through in the descriptive characteristics of this sample, and may shed some light in 
understanding the findings of this study. 
Measures of the marital partner status and the history of substance use variables 
were included in the maternal-fetal attachment model because they capture participants’ 
socio-demographic characteristics, which  are theoretically and empirically associated to 
the maternal health behaviors investigated in this study (Burns et al., 2008; Demas et al., 
2005; Mellins et al., 2003; Riley et al., 2011). Most of the participants in this study 
reported being single or not living with a marital partner, regardless of this partner being 
the father of the infant they were expecting. Our finding differs from the demographics 
reported in previous research, which indicate a more even split or greater likelihood of 
reporting a marital relationship among pregnant women living with HIV/AIDS (Ethier et 
al., 2002; Mellins et al., 2008).  
The findings in this sample regarding history of substance use compared to earlier 
reports suggest similarities in the use of licit (smoking and alcohol) and illicit drugs 
(marihuana, cocaine, crack-cocaine, or injection) among HIV-infected pregnant women 
during the 30 years history of the HIV epidemic (Cohn et al., 2008; Ethier et al., 2002; 
Turner et al. 1996). However, the drug of choice reported by the participants may have 
changed. Specifically, the women in this study did not report any history of injection drug 
use, which at the beginning of the HIV epidemic was the main transmission mode for 
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women; injection drug use was from the earliest days of the epidemic a known risk factor 
for AIDS and for HIV infection (CDC, 1982; Bardaguez et al., 2008; Ethier et al., 2002). 
Aside from the four women who reported acquiring HIV from their own mothers, 
heterosexual intercourse was the main mode of transmission for the participants in this 
study, and they learned their HIV diagnosis while receiving prenatal care for the current 
or previous pregnancies.       
 Pregnancy-related characteristics. Contrary to the findings reported by Ethier et 
al. (2002) from research conducted between 1996 and 1999, and similar to those findings 
from an investigation conducted between 2002 and 2005 by Cohn et al. (2008), the 
majority of participants did not plan this pregnancy (68%). Among those women 
reporting unplanned pregnancies, 54% reported not preventing it either. The women’s 
perceptions about HIV as a chronic, versus a terminal illness, and the efficacy of the 
protocol to prevent mother-to-child HIV transmission may have led to lower vigilance in 
safe sex and reproductive planning practices. Ironically, advances in HIV prevention of 
mother-to-child transmission and treatment may explain the observed rising percentage of 
unplanned pregnancies. In addition, the percentage of unplanned pregnancies reported in 
this sample by far exceeds the U.S. proportion of pregnancies (37%) unintended at the 
time of conception, but resembles the proportion of unintended pregnancies among non 
Hispanic Black, unmarried, and low-income women, who were overrepresented in this 
sample (Mosher, Jones & Abma 2012).   
 The findings of this study regarding frequencies of early prenatal care (i.e., 
pregnancy-related care beginning in the first trimester of pregnancy; 37%), low birth 
weight (17%) and preterm birth (18%) among the women in this sample compared 
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favorably to the findings reported by Turner et al. (1996) after examining prenatal care 
and birth outcomes in a large cohort (N = 2254) of HIV-infected women delivering 
infants between 1985 and 1990 (20%, 28%, and 23%, respectively); and unfavorably 
with recent U.S. indicators of maternal and infant health (83.7 %, 8.1% and 12%, 
respectively; March of Dimes, 2013). On the one hand, the favorable comparisons could 
lead to the conclusion that HIV-infected women now practice improved health behaviors 
to access prenatal care early and reduce the frequency of low birth weight and premature 
birth among their newborns. On the other hand, a large gap still exists between the rates 
of specific maternal and infant health indicators observed in this sample, and those 
calculated for all recent births in the U.S. (March of Dimes, 2013). However, macro-
structural factors must be considered in the interpretation of these results (Riley et al., 
2011; Turner et al.). For example, the lack of health insurance associated with poverty 
often delays women’s entry into prenatal care, regardless of their motivation; and the 
health disparities associated with the racial or ethnic background of participants may 
perpetuate this gap beyond their control. The findings reported by Ethier et al. (2002) on 
the proportion of HIV-infected women who registered into prenatal care at or before 19 
weeks gestation (i.e., early entrants; 78.7%) is comparable to the findings of this study 
(74 %). This similarity strengthens the argument presented above, in favor of HIV 
pregnancy outcomes similar to the U.S. norm, because by extending the criterion for 
early entrants into prenatal care by 6 weeks of gestation (i.e., from 13 to 19), the 
proportion of women in this category moves further away from Turner et al. (1996) 
findings toward the U.S. parameter of maternal and infant health.   
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Consistent to findings in the research literature regarding the caregiving 
responsibilities of women living with HIV, most of the participants in this study (82%) 
are caregivers for one or more children, often singlehandedly (Murphy et al., 2002; Kates 
et al., 2013). Only 12% of the women reported this pregnancy as their first. The frequent 
deliveries by caesarean sections (68%) assessed in this sample are more than twice the 
rate reported for the U.S. population in 2010 (32.8%; March of Dimes, 2013). However, 
the protocol for the prevention of the mother-to-child HIV transmission indicates the use 
of this type of delivery in reducing the risk for transmission in women who have not 
achieved a low or undetectable viral load (DHHS Panel on Treatment of HIV-infected 
Pregnant Women and Prevention of Perinatal Transmission, 2011). This indication may 
explain the elevated frequency of cesarean deliveries in this sample.   
 HIV-related characteristics. Consistent with findings reported in previous 
studies, including those with time frames in the early 2000s, the majority of women in 
this sample strive for health during pregnancy, and become healthier as indicated by 
biomarkers (low HIV viral loads and high CD4 cell counts) assessed before delivery 
(Bardaguez et al., 2008; Cohn et al., 2008; Mellins et al., 2008). Also most women were 
diagnosed only with HIV disease not AIDS at the beginning of pregnancy (Bardaguez et 
al., 2008; Cohn et al., 2008; Mellins et al., 2008). Indeed, the impressive advances in the 
treatment of HIV disease with antiretroviral medication, and the protocols for the 
prevention of mother-to-child transmission afford women the benefits of health during 
pregnancy and beyond, for them and the infants they are expecting. This benefit assumes 
the women access prenatal care early, attend scheduled prenatal care visits, and adhere 
consistently to prescribed medication regimens. An additional challenge for researchers 
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regarding the majority of women has been to identify barriers and facilitators that will 
help them sustain this rush to health beyond pregnancy, after childbirth, and extend it to 
the care of the infant (Bardeguez et al., 2008; Mellins et al. 2008). Then, social workers 
could develop effective interventions aiming to remove barriers and promote facilitators 
for the sustained health and wellbeing of these mothers and infants. Ickovics et al. (2002) 
found a decline in medication adherence from pregnancy to the postpartum period, from 
low to very low; however, in contrast to findings in this and previously discussed studies, 
they reported low adherence during pregnancy. The 31% of women in this sample who 
show detectable amounts of viral load and low CD4 counts could be interpreted in this 
study as having poor adherence and/or poor response to the prescribed ART regimens. 
The clinical and psychosocial situations of this group of women pose multiple challenges 
for health practitioners, such as engaging and maintaining them in prenatal care, 
promoting medication adherence to lower their viral loads, and planning an optimal 
delivery for the prevention of mother-to-child transmission. This may be the same group 
of women who also challenge pediatric practitioners by showing inconsistent attendance 
or completion of HIV PCR test during postnatal screening visits for the infants.    
Compared to findings reported by Ickovics et al. (2002), this study found a 
smaller number of women learning about their HIV diagnosis during this pregnancy 
(37% and 20%, respectively). This difference in newly diagnosed women at a given 
pregnancy fits the decline in new cases of HIV infection among women for the year 2010 
reported by the CDC (The Kaiser Family Foundation, 2013). Although the majority of 
women in this sample learned about their HIV diagnosis before this pregnancy, they had 
lived less than six years with the disease. The relatively small number of years since 
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diagnosis parallel findings from studies conducted in the early to mid 2000s, and contrast 
with the findings from studies conducted in the late 1900s.   
Summary. Findings regarding sociodemographic, pregnancy, and HIV disease 
characteristics among this sample of pregnant women with HIV suggest an evolution 
parallel to the evolution of the HIV epidemic in general. The minority ethnic and racial 
composition, the low income levels, and the use of substances may have persisted among 
women coping with pregnancy and HIV/AIDS. Conversely, the level of education, and 
some indicators of less severe and advanced HIV disease such as high rate of 
undetectable viral loads, low rates of AIDS diagnosis, and newly diagnosed women may 
have improved since the beginning of the HIV epidemic. This improvement appears to 
approximate today’s HIV-infected mothers to some of the normative indicators of 
maternal and infant health such as early entry into prenatal care, and rates of premature 
births or low birth weights among HIV-exposed infants. Whereas Black and Hispanic 
indigent HIV-infected pregnant women appear healthier now than in past years of the 
HIV epidemic, still more work remains to be done before they could enjoy the full 
benefits of the advances in HIV medicine (Riley et al., 2011). 
Associations Between Maternal-Fetal Attachment and Health Behaviors 
 In contrast to the medical model used in previous studies to investigate health 
behaviors—mostly adherence to antiretroviral medication—among this population of 
pregnant women, the maternal-fetal attachment model used here represents a 
socioecological and developmental model to assess health behaviors across time from 
mid pregnancy to 16 weeks after childbirth. This model investigates the health behaviors 
of HIV-infected women from a strength-based, instead of a deficit-based framework; 
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includes facilitators for optimal, instead of only risks for poor, health behaviors; and 
developmentally extends the scope of health behaviors beyond medication adherence to 
measures of health behaviors for pregnancy and infant care (Saleebey, 2006). The study 
findings partially support the potential protective role of maternal-fetal attachment among 
HIV-affected mothers and infants against poor maternal health behaviors. 
This study found that a maternal-fetal attachment model predicts the health 
behaviors related to pregnancy care among HIV-infected pregnant women; however only 
three of the five predictors (i.e., maternal-fetal attachment, living with a marital partner 
status, and planning the pregnancy status) contribute substantially to the large effect size 
observed in this predictive relationship. The hypothesized model failed to predict the 
health behaviors associated with antiretroviral medication adherence and virologic 
response, and infant care across time. However, the effect sizes observed in the 
relationships between the maternal-fetal attachment model and these maternal health 
behaviors ranged, respectively, from medium to medium-large.  These findings offer only 
partial support to the study’s hypothesis; however they add emerging credence to similar 
associations suggested in the qualitative research literature (Ciambrone et al., 2007; 
D’Auria et al., 2006; Kelly et al., 2012; Njie-Carr et al., 2013). It also suggests potential 
benefits in attending to the relationship a woman has with her unborn child perhaps as an 
additional component of her prenatal care to possibly help resolve her struggles with 
health behaviors. Does attending to this prenatal relationship promote her health 
behaviors by focusing on the woman-identified aspirations and possibilities, rather than 
the expert-identified barriers and problems (Saleebey, 2006)? Are health practitioners 
missing the opportunity to address an influential dimension in the experiences of HIV-
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infected women, at least during pregnancy? The following discussion of main results 
considers these questions, and raises further questions about the fitness of the maternal-
fetal attachment model tested here.  
Pregnancy care. This study found a large effect predictive relationship between 
the maternal-fetal attachment model and the health behaviors for pregnancy care, and 
maternal-fetal attachment made the strongest contribution in predicting this health 
behavior outcome. This study is original in examining a maternal-fetal attachment model 
on the health behaviors of pregnant women with HIV/AIDS. Lindgren (2001) found a 
weaker significant predictive relation of a different maternal-fetal attachment model 
examining the health behaviors of a completely different sample of pregnant women: 
uninfected, White, highly educated women of high socioeconomic status. Together, the 
findings from these two samples suggest that the higher the stakes in the pregnancy, the 
stronger the influence of maternal-fetal attachment in predicting optimal health 
behaviors. Second, it suggests that HIV-infected pregnant women who have stronger 
attachment to the unborn child on average take better care of their health during 
pregnancy. However, one cannot necessarily imply from this finding that a woman with 
high levels of maternal-fetal attachment would protect her unborn child against the 
transmission of HIV, and other adverse pregnancy outcomes, by practicing optimal 
prenatal health behaviors.  
 Any of the limitations identified earlier may explain this finding rather than the 
existence of a true predictive relationship between maternal-fetal attachment and this first 
maternal health behavior. For example, the positive association could be attributed to the 
overlap in the items included in the scales measuring maternal-fetal attachment (MFAS) 
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and health behaviors for pregnancy care (HPQ-II). However, despite the uncertainties in 
interpreting a finding from regression analysis from one single study, it still represents a 
promising research path for building knowledge about this association. Future 
replications may consider the strengths and limitations of this study to further explore this 
relationship. They could first investigate variables (e.g., timely access and adequate 
duration of prenatal care) not explored in this study, which may have even a more 
important influence than maternal-fetal attachment on maternal health behaviors. Still 
63% of the variance in the proposed linear model of health behaviors remains 
unexplained, not an unusual result in modeling complex behaviors.   
Furthermore, cautiously avoiding over interpretation of the contributions from 
each of the predictors in the maternal-fetal attachment model, the analysis of the predictor 
variables could also be promising in researching maternal health behaviors among 
women with HIV/AIDS. Specially those emerging as potential predictors of maternal 
health behaviors for pregnancy care, marital partner and planned pregnancy statuses.  The 
finding regarding the marital partner living status is consistent with several isolated 
reports from the research literature linking single parent status, or lack of social support, 
in general, to poor health practices among HIV-infected women (Demas et al., 2005; 
Mellins et al., 2003). Napravick et al. (2000) using a deficit-based framework found that 
lack of support and unplanned pregnancy were among the most important barriers for 
HIV-infected women in accessing prenatal care. However, when extrapolating and 
comparing findings from previous research one must be critical about several issues 
related to definitions of the predictor variables, and ecological differences among the 
cohorts of HIV-infected women investigated in each study.   
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Nevertheless, the finding regarding these two predictors of maternal health 
behaviors could be tentatively interpreted from the logic of the strength-based maternal-
fetal attachment model for the women in this sample. Some of the women in this sample 
who live with a marital partner may experience this relationship as emotionally 
supportive, a major resource during pregnancy (Dunkel-Schetter’s et al., 2001). 
Especially, in the context of HIV disease, experiencing a supportive marital relationship 
may alleviate the isolation and stigma still associated with this disease (Saleebey 2006). 
The marital partner or the relationship itself, may motivate, or facilitate the practice of 
optimal prenatal health behaviors (Lindgren, 2001). Alternatively, accounting for the 
negative direction between this predictor and prenatal health behaviors in the entire 
maternal-fetal attachment model, one could interpret that in the absence of a supportive 
marital relationship a woman draws hope from the affectionate relationship with her 
unborn child (Lindgren, 2001). Then, her investment on adopting a healthy life style 
becomes a paramount task. Does maternal-fetal attachment take a more central role in 
predicting prenatal health behaviors when a woman lacks the support of a marital 
partner? Does this finding suggest the hypothesis of a buffering effect of maternal-fetal 
attachment on the adverse circumstances in the experience of HIV-infected pregnant 
women?  
When a woman plans a pregnancy while coping with HIV disease, she makes a 
very purposeful, potentially life transforming decision. Implicit in this decision is her 
intention to take charge of her health, her future, and perhaps her dreams of becoming a 
mother (Kelly et al., 2012). A planned pregnancy brings along a strong attachment to the 
child she expects, an impetus to adopt healthy life styles, and a willingness to adhere to 
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HIV treatments (Njie-Carr et al., 2013). She may invest herself in practicing optimal 
prenatal health behaviors to protect her child from harm and deliver an uninfected infant. 
However, only slightly less than a third of the participants in this study planned their 
pregnancy. Are the women in this sample affected by a now subtle, or perhaps insidious, 
social stigma supporting the belief that women living with HIV/AIDS should not 
reproduce or plan for a family? Is this social stigma preventing them from disclosing their 
HIV status in the context of family planning or reproductive health services in the 
community, and accessing these services? The policy and practice implications of this 
possibility are discussed below. 
A supportive marital relationship and a planned pregnancy are conceptualized as 
protective resources for the health practices of pregnant women in general, with and 
without HIV/AIDS in Dunkel-Schetter’s et al.’s (2001) bio-psychosocial theoretical 
model of stress processes in pregnancy, and the Bronfenbrenner’s (1979) socio-
ecological theory on child development. One could consider that these predictor variables 
might even be more applicable in a protective role for the participants in this study. This 
knowledge has long been part of the theoretical foundation of well-established and 
efficacious home visiting, maternal-child health, and parenting, prevention and 
intervention programs for the general population of low-income or minority families in 
need (Mosher et al., 2012). Interestingly, since its inception, the Healthy People national 
health initiative has embraced a goal that aims to reduce the percentage of all unintended 
pregnancies in the U.S. by 2020 (Mosher et al.). The question remains, how do these 
universal theories and initiatives for pregnant women, mothers and infants apply to the 
cohort of women in this study?  
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As the HIV epidemic evolves beyond its third decade, are HIV-infected pregnant 
women and HIV-affected families becoming more similar to their uninfected counterparts 
(Ethier et al. 2002)? Or are researchers and practitioners failing to assess subtle but 
important differences?  Should practitioners use the similarities to empower HIV-affected 
families and also carefully assess the differences, working in partnership with the women, 
to inquire and respond more effectively to their unique psychosocial needs (Saleebey, 
2006)?  
 The finding about the role of a history of substance use in predicting maternal 
health behaviors for pregnancy care is difficult to interpret probably because this study 
included only one question in the analysis of this variable, despite using several questions 
to measure it. Nonetheless, its contribution to the medium predictive relationship 
assessed in this regression analysis is minimal. In contrast, multiple studies in the 
research literature found relationships between poor health behaviors among HIV-
infected pregnant women and either a history of substance use, a substance abuse 
diagnosis, or an active substance use problem (Burns et al., 2008; Mellins et al., 2003; 
Napravick et al., 2000).  Do variables measuring risks for poor maternal health behaviors, 
such as history of substance use diminish when examined in conjunction with potential 
protective factors against adversity or facilitators of wellbeing?  The task of testing mixed 
models of risk and protective factors related to maternal health behaviors is complex but 
it may help elucidate some of the actual dynamics of these factors in the lives of these 
women.  
The predictor variable of the timing of HIV diagnosis (i.e., before or during this 
pregnancy) remains puzzling. This analysis fails to offer much insight into this variable 
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probably because only a fifth of the women in this sample reported being diagnosed with 
HIV during the current pregnancy. In addition, the measurement of this variable consisted 
on a sequence of three questions, but the response to only one of these questions was 
included in the analysis.  Certainly, this predictor variable needs further exploration in 
future studies. This predictor was included in the maternal-fetal attachment model mostly 
for exploratory purposes based on clinical observations and theoretical leads in the 
literature review describing striking differences between coping styles and impact of 
diagnosis and disease among the women diagnosed with HIV during or before a given 
pregnancy (Kotze et al., 2013; Tareq et al. 2012). 
 Medication adherence. Contrary to the study sub hypothesis, no predictive 
relationship was found between the maternal-fetal attachment model and the maternal 
health behaviors for medication adherence in this sample of HIV-infected pregnant 
women. Some of the limitations of this study may account for this finding; at the same 
time many of the strengths of this study support the rigor of this specific analysis. Some 
of these strengths and limitations in the analysis of this maternal health behavior are 
discussed ahead.  
 The measurement of adherence to antiretroviral medication in pregnant women is 
not a simple task. Whereas the HIV-1 viral load counts abstracted from the maternal 
medical record are considered the most objective and reliable, albeit indirect, measure of 
levels of ART adherence for the women in the sample. However, limiting this measure 
only to viral load counts present some challenges, even when these counts were closely 
monitored across the duration of the pregnancy, in preparation for delivery. A very high 
viral load after six months of ART would suggest low adherence, while an undetectable 
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viral load would suggest perfect or close to perfect adherence.  However, factors other 
than medication adherence or related to imperfect medication adherence, but beyond the 
women’s control could explain a high viral load in certain cases. Brief prenatal care time, 
very high pre-ART initiation viral load, pharmacokinetic issues related to other medically 
prescribed or alternative medications, or unsuspected antiretroviral resistance are among 
the factors other than medication adherence, which would account for a high viral load 
count. For example, a woman entry into prenatal care late in the course of the pregnancy 
with a high viral load would not allow time to perform an antiretroviral resistance test on 
her strain, resolve any resistance if needed, and lower her viral load count by the time of 
her delivery.  In other cases, several financial, environmental or psychosocial factors 
outside of a woman’s control could interfere with her ability to access medication or 
ingest the medication as prescribed (Firth et al., 2012; Riley et al., 2011). For example, 
gaps in health coverage for prescription drugs, pharmacy mistakes in filling or delays in 
delivering the medications, lack of food to accompany some of the medications, 
unexpected hospitalizations for other medical conditions, homelessness, or incarceration 
compromised the women’s ability, in this sample, to adhere to their medication regimen. 
Information about these factors was available to the PI from the nurses’ case notes in the 
maternal medical record, reports by the PRIM team during pre-clinic conferences, or 
direct observations in clinic. Additionally, the undetectable HIV-1 viral load counts 
abstracted from the maternal medical records were recorded by the obstetric practitioners 
either with numbers (e.g., < 20 or < 50) or letters (ND for non detectable), already 
reflected each practitioner’s personal clinical interpretation of the different sensitivities of 
the HIV tests used in the lab to detect levels of the virus in the blood specimen (Cobbs et 
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al., 2011). Recording procedures of the undetectable viral load may have varied by 
obstetric practitioner, creating inconsistencies which may have led to errors. 
Nevertheless, many of the difficulties described above were carefully considered and 
addressed when performing the data abstraction and recording from the maternal medical 
record or the data screening and log transformation processes on the measurement of HIV 
viral load in this study. In addition, the distribution of the log transformed HIV viral load 
data satisfied required assumptions for the use of a parametric test, which in comparison 
to an alternative non parametric test may prove a more powerful and efficient statistical 
analysis to test this sub hypothesis.  
 The rigor of this regression analysis, including the resulting undesirable sample 
size attrition, could explain the medium effect size assessed for the prospective 
relationship between the maternal-fetal attachment model and maternal health behavior 
for medication adherence.  On the one hand, an unidentified bias in this non randomized 
sample may have led to the inaccurate assessment of a medium to large effect size 
(Slavin and Smith, 2009). On the other hand, avoiding the division of this continuous 
variable into dichotomous categories of medication adherence (i.e., adherence and non 
adherence) may have enhanced the rigor of this analysis to detect a medium effect size 
(Hansen & Collins, 1994). Moreover, the outliers in the distribution of this outcome 
variable were the women who presented late for prenatal care either with unknown last 
HIV viral load before delivery, unknown resistance, or very high viral loads. In fact, one 
of the above cases is listed in this regression analysis output as an unusual one showing a 
large discrepancy between the predicted and the observed value of (log of) viral load 
(ART adherence). Although these outliers passed the screening performed here, 
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recommending against their removal, they may have exerted an undue influence in this 
multivariate regression analysis. Alternatively, it is possible that a mother was strongly 
attached to her unborn child, but that other circumstances in her life discouraged her from 
taking ART during pregnancy and delayed her decision to receive prenatal care until very 
close to delivery. Finally, the marked heterogeneity of this sample in terms of cultural 
background and HIV disease trajectory may also have contributed to decreased power to 
detect the hypothesized association between the maternal-fetal attachment model and 
maternal health behaviors for medication adherence, as measured by virologic response 
(Hansen & Collins, 1994).          
Assuming for a moment some validity of this and the previous findings, they may 
suggest that the large effect of the MFA model in predicting the pregnancy-related health 
behavior does not extend or, at least, fades away in this second health outcome in the 
hypothesized model. It contradicts suggestions in the qualitative literature of a 
relationship between maternal prenatal concerns for the health of the fetus and 
medication adherence during pregnancy (Ekama et al., 2012; Kelly et al. 2012). It argues 
against the anticipated permeation of pregnancy care to HIV care health behaviors as 
suggested by Bardeguez et al. (2008). Although participants take care of the pregnancy 
and the HIV disease at once, reportedly for the benefit of the unborn child, does this 
finding suggest that the two sets of maternal health behaviors are not connected, or 
perhaps are of a completely different nature? Is the influence of maternal-fetal attachment 
on maternal health behaviors short lived and limited to the pregnancy-related behaviors 
as suggested by Kotze et al. (2013) among South African women diagnosed with HIV 
during pregnancy?  
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The variables measuring time of entry into prenatal care, total number of prenatal 
care visits attended, and ethnicity examined in the exploratory analysis (Table 13) may 
shed some light on possible lurking variables influencing this prospective relationship. 
The associations between these variables, maternal-fetal attachment and the (log of) viral 
load as a measure of adherence are suggestive in different ways. The variables related to 
entry and duration of prenatal care combined with the expected number of prenatal visits 
recommended by the American College of Obstetrics and Gynecology for uncomplicated 
pregnancies, and the gestational age at delivery become the measure of the adequacy of 
initiation of prenatal care (March of Dimes, n.d.). Then, this measure combined with the 
adequacy of received prenatal services becomes a summary index measuring adequacy of 
prenatal care. Turner et al. (1996) and Napravnik et al. (2000) used two different 
measures of adequacy of prenatal care to assess, respectively, relationships between the 
adequacy of prenatal care and birth outcomes and optimal utilization of prenatal care 
among pregnant women with HIV/AIDS. Rachas et al. (2013) also concluded that for 
some women the short duration of HIV treatment may explain their inability to achieve 
an undetectable viral load. Interestingly, the exploratory analyses performed in this study 
show a medium positive correlation between maternal-fetal attachment and the number of 
prenatal care visits variables (Table 13). The concept of adequacy of prenatal care 
emerges as promising in the investigation of the health behaviors for medication 
adherence among HIV-infected women. Furthermore, this construct may help understand, 
if any exists, the links between maternal-fetal attachment, pregnancy- and HIV-related 
health behaviors in this cohort of pregnant women.  
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The correlation between the variable measuring Hispanic ethnicity, and the (log 
of) viral load could possibly refer to the unique difficulties faced by the Hispanic 
participants in this study, related to their immigration and/or health insurance status, in 
accessing early prenatal care or undisrupted antiretroviral medication (Firth et al., 2012). 
As suggested in the literature, the influential factors on medication adherence seem to be 
multidimensional and multidirectional, especially when examined prospectively –not 
only comparatively before and after pregnancy– across the pre and postnatal period for 
women living with HIV/AIDS (Nachega et al., 2012). The post hoc t test conducted to 
examine the mean differences between Hispanic and non Hispanic participants on the 
measure of (log) viral load as medication adherence revealed that the latter exhibited, on 
average, lower viral loads (higher medication adherence) than the former. The finding of 
a large effect size of the difference in medication adherence relative to ethnicity adds 
evidence to the likelihood of above   interpretation. The health behaviors of HIV-infected 
pregnant women and mothers related to antiretroviral medication adherence are 
embedded in various favorable and adverse psychosocial circumstances, which interact in 
different ways at different moments of their lives in the period surrounding childbirth 
(Kotze et al. 2013).  
 Postnatal pediatric visits. The present study found a non-predictive relationship, 
and a medium to large effect size between the maternal-fetal attachment model and the 
maternal health behavior for infant care. Some of the limitations of this study may 
account for this finding. For example, the use of a random sample and the extension of 
the study period to accommodate the completion of the screening visits for all 82 
recruited participants could have changed the results of this analysis by increasing its 
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power to detect this hypothesized predictive association. The coding procedure of the 
variable measuring attendance to the scheduled screening clinic appointments for the 
infants was revised to accommodate those mothers who do not attend their infants’ 
medical appointments but they manage to have them tested elsewhere. Whereas this 
revision may have improved the appropriateness of this measure, using attendance and 
test performed to measure maternal health behaviors for infant care may have been 
insufficient. Could the medium to large effect size observed in this regression analysis 
compared to the medium assessed for medication adherence suggest a greater affinity of 
maternal-fetal attachment with the maternal health behaviors for infant care than those 
related to HIV care?    
A quantitative international study investigated the factors related to maternal 
adherence to the medical appointments for herself and her infant using a cohort of 169 
French HIV-infected mothers in a 24-month longitudinal and retrospective design (Lemly 
et al., 2007). France and the U.S. are developed countries that invest resources in 
advancing the medical treatment for HIV disease during pregnancy; however, their health 
and cultural value systems differ in that the French population has universal health 
coverage, among some other differences. Comparisons between Lemly’s et al. findings 
and those of the current study may not apply due to these differences; however, the 
former may still shed some light in attempting to understand the latter. Lemly et al. 
(2007) found a strong association between attendance to maternal and infant follow up 
medical visits and, similar to the findings of the current study, the majority of mothers 
(79% and 77% respectively) demonstrated regular attendance to the follow up medical 
appointments for their infants. In addition, both studies observed that some mothers did 
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not adhere to their own treatment, yet they regularly brought the children to their 
scheduled medical appointments. Similar to the present study, Lemly et al. examined the 
role of marital living status, defined as living with or without a male partner, in this 
maternal health behavior; and found that this variable was not significantly associated 
with the postnatal maternal health behaviors. The secondary role of the marital living 
status in relation to postnatal maternal health behavior could be interpreted as the 
relevance of the new emotional support drawn from the attachment to her infant over the 
relationship to her marital partner. Furthermore, Lemly et al. found that regular 
attendance to the medical appointments for her and her  infant after childbirth were 
significantly associated with the greater numbers of HIV-related prenatal visits and the 
prescription of combination antiretroviral therapy (as opposed to zidovudine 
monotherapy) during pregnancy. Could the frequency of prenatal visits and the number 
of antiretroviral pills during pregnancy also predict the maternal postnatal health 
behaviors in the U.S. as it did in the French cohort (Lemly et al., 2007)? Apparently the 
women diagnosed with HIV before this pregnancy, or even those with more advanced 
HIV disease, may have an advantage over the women diagnosed with HIV during this 
pregnancy because the former possibly attend more prenatal visits, earlier in pregnancy, 
and were more likely to receive combined therapy regimens. If so, the women with pre-
pregnancy HIV diagnoses would demonstrate more optimal maternal behaviors for infant 
care compared to those with new HIV diagnoses. Alternatively, the knowledge and 
experience of the screening protocol from a previous pregnancy may relax compliance 
with the current medical appointments. For example, they may skip the third appointment 
in the protocol knowing that it involves counseling, not HIV DNA PCR testing of the 
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infant. They may also be less anxious about the screening process, and more trusting of 
the medical team.  
The question still remains unanswered by the findings in this single study: Does 
the use of a maternal-fetal attachment model hold promise to investigate the connections 
between the pregnancy- , HIV- , and infant-related health behaviors of HIV-infected 
women?  After all, MFA clearly originates in pregnancy and transforms, in unknown 
ways for now, into actual mother-infant attachment after childbirth. However, the 
findings of this study contributed to reassessing the connections between maternal-fetal 
attachment and medication adherence and response to HIV care as counterintuitive and 
complex, almost a forced detour in maternal-fetal attachment development; and to 
explore one potential variable, adequacy of prenatal care, that although not included in 
the model tested here (Grace, 1989) may influence the predictive relationship between 
maternal- fetal attachment and maternal health behaviors.     
Future Studies  
Future investigations could use the strengths and limitations of this study to 
further examine the relationships between maternal-fetal attachment and maternal health 
behaviors in pregnant women living with HIV/AIDS. The recruitment of a large 
randomized, perhaps multi-site sample of pregnant women living with HIV/AIDS would 
strengthen the external validity of findings and justify the interpretation of the 
significance of the statistical analyses (Kam et al., 2007).  The findings from such sample 
of participants could be generalized to others within this population.  Such study could be 
extended in  duration  to maintain the prospective design by either recruiting a larger 
sample, or allowing for the completion of the 16-week screening protocol after the birth 
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of all infants whose mothers were recruited in the study, or both (Hansen & Collins, 
1994). Future studies could consider the translation of instruments into Creole and 
reaching out to other private or public obstetric clinics in the community to recruit more 
inclusive samples than the one used in this study.  
Future research may need to refine the conceptualization of the MFA construct, 
further exploring its different dimensions (e.g., protection of the fetus, motherhood role, 
and attributions of characteristics to the fetus). Future studies could consider the use of 
structured interviews to assess a qualitatively dimension of maternal-fetal attachment 
(e.g., The Pregnancy Interview-Revised; Slade, 2007) in addition to its quantitative 
characteristics. The use of multi-measure approaches could improve the measurement of 
maternal health behaviors for medication adherence and pregnancy care. For example 
future studies could combine HIV viral load and other more direct measures of 
medication adherence such as self-report, electronic monitoring, pill count or pharmacy 
refills to add validity to this measurement (Williams et al., 2013). They could use a 
revised abbreviated HPQ-II scale, or the 34-item version of the HPQ-II scale to improve 
the reliability of this instrument.  
Future studies investigating the maternal health behavior for infant care could use 
a more comprehensive measurement of this outcome variable instead of only attendance 
to the screening visits or completion of the HIV test for the infant, as done in this study. 
Such composite measure of maternal health behavior for infant care could include other 
indicators of postnatal maternal caregiving (e.g. mother-infant attachment) or variables 
measuring the psychosocial barriers interfering with maternal caregiving (e.g., health 
insurance coverage).  
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Summary  
The main hypothesis regarding a prospective relationship between maternal-fetal 
attachment, other relevant predictors, and health behaviors for pregnancy care, ART 
adherence and infant care was only partially supported by the findings in this study. The 
predictive relationship between the maternal-fetal attachment model and the pregnancy-
related health behaviors showed a large effect size. Maternal-fetal attachment, marital 
partner status, and planned pregnancy status contributed in that order to the predictive 
ability of the model. This model did not predict the maternal health behaviors related to 
ART adherence and virologic response or infant care. However, the relationships 
observed between these variables and the maternal-fetal attachment model showed a 
medium to large effect. The concept of adequacy of prenatal care emerged in the 
exploratory analyses as promising to further investigate the prospective relationships 
hypothesized in this study. 
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CHAPTER VII: IMPLICATIONS FOR SOCIAL WORK 
The theoretical relevance of MFA to the prevention of poor health behaviors and 
suboptimal infant care by promoting prenatal maternal caregiving and postnatal 
attachment seems well grounded. This investigation found a large predictive association 
between maternal-fetal attachment and other relevant predictors and the maternal health 
behaviors for pregnancy care among pregnant women with HIV/AIDS, from a strength-
based and socio-ecological developmental framework. Altogether, the theoretically 
conceived predictor variables, the prospective design, medical record-abstracted objective 
measures of health behaviors, a back translation of study instruments into Spanish, and an 
infant-related outcome variable utilized in this study ensured a reasonable level of 
internal validity. At conceptual, practical, and policy levels, this study dovetails with the 
aims of infant mental health interventions and child maltreatment prevention agendas. 
Some implications for research, interventions and policy suggested by the findings are 
presented next.   
Research  
The overall findings of the present study suggest the need for additional research 
to further explore the potential role of maternal-fetal attachment in predicting the 
maternal health behaviors among women with HIV/AIDS. The maternal-fetal attachment 
experience of these pregnant women appears associated to their health behaviors, at least 
those related to pregnancy care; yet very little is known about this dimension of their 
pregnancy (Lindgren 2001). Future studies could further assess the full scope of their 
maternal-fetal attachment experience, including which dimensions of this experience 
impact their health behaviors during pregnancy and after childbirth. The current findings 
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revealed that the majority of participants experience high levels of maternal-fetal 
attachment and practice high levels of pregnancy-, HIV-, and infant-related maternal 
health behaviors. However, given the limitations of this study the prospective relationship 
between maternal-fetal attachment and maternal health behaviors remains unclear. 
Maternal-fetal attachment showed a large effect size relationship to the pregnancy-related 
maternal health behaviors in this sample of women, but further investigation is necessary 
to examine the influence of maternal-fetal attachment and other predictors on HIV- and 
infant-related maternal health behaviors.    
The measurement of the living marital status, history of substance use variables, 
and maternal health behaviors for infant care may need refinement relevant to the cohort 
of women in this study in order to ascertain predictive relationships between MFA and 
maternal health behaviors.  The use of follow up questions to measure the supportive or 
problematic characteristics of the marital relationship of the women, or the extent and 
nature of the substance use history could help elucidate the role of these predictors on 
maternal health behaviors. In addition, the use of a composite measure to measure the 
maternal behaviors for infant care would collect additional relevant data about this 
variable. Such measure could include other indicators of postnatal maternal caregiving 
like a mother’s planning for infant care in anticipation of barriers, or the mother-infant 
attachment itself. For example, one participant arranged for a family member to bring her 
infant to the screening clinic appointment because she was temporarily incarcerated for a 
domestic violence incident.  A composite variable could also measure the psychosocial 
barriers interfering with postnatal maternal caregiving such as health insurance 
difficulties to access the screening visits or HIV testing for the infant, hospitalizations or 
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medical complications for mother or infant, or lack of family support due to the secrecy 
and stigma surrounding HIV disease.  
The current exploratory findings suggest the possible relevance of the variables 
measuring time of entry into prenatal care and total number of prenatal care visits, to 
further explore prospective relationships between maternal-fetal attachment and maternal 
health behaviors among this cohort of HIV-infected women (Napravick et al., 2000; 
Turner et al., 1996). Conceptually, these two variables fall in the realm of the construct 
defined as ‘adequacy of prenatal care’ in the pregnancy literature. Future studies could 
consider the inclusion of this construct in exploring prospective relationships between 
maternal-fetal attachment and maternal health behaviors before and after childbirth 
among women with HIV/AIDS.   
A study using qualitative methods could contribute new conceptual material 
regarding the possible relationships between maternal-fetal attachment and maternal 
health behaviors by collecting detailed narratives on the maternal-fetal attachment 
experience and their choices of health behaviors (Njie-Carr et al., 2013). Do women 
choose optimal health behaviors when their maternal-fetal attachment experience reflects 
a strong affiliation with their unborn child, and grounds itself in other past childhood and 
present adult secure attachments (Slade, 2007)? A qualitative study may also capture the 
nuances and complexity of measuring the maternal health behavior for infant care from 
the women’s perception. Finally, it could be useful to replicate Lemly’s et al. (2007) with 
a U.S. cohort of HIV-affected mother and infant pairs to simultaneously investigate 
attendance to maternal and infant follow up HIV-related medical appointments.  
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This study contributes to the existing research literature examining the health 
behaviors in pregnant women living with HIV/AIDS by introducing the use of a socio-
ecological, strengths-based and developmental approach. Maternal-fetal attachment 
represents a theoretical shift from a medical deficit-based model to a developmental 
strength-based model, and the integrated approach offers an alternative or complementary 
framework to the exclusive medical approach, most often found in the relevant research 
literature.  Previous studies examined the maternal health behaviors in HIV-infected 
women almost exclusively by comparing measures of ART adherence during and after 
pregnancy (Demas et al., 2005; Ikovicz et al., 2002). A maternal-fetal attachment 
integrated approach opens the door to examining a wider range of maternal health 
behaviors (i.e., pregnancy-, HIV-, and infant-related) prospectively across time. On the 
one hand, a medical model examines and interprets health behaviors from the lens of HIV 
disease, an unfortunate occurrence in the lives of these mothers. On the other hand, when 
using a maternal-fetal attachment model, the perspective becomes that of a woman 
preparing to give birth and nurture her infant, while coping with HIV/AIDS (Bywaters 
1986). In the long term, this integrated approach could lead to the implementation of 
innovative and interdisciplinary research in the fields of HIV/AIDS, maternal and child 
health or the socio-emotional development of young children. Some of these research 
teams could reach out to the HIV-affected families in the communities where they live 
and conduct participatory research investigating the potential prospective relationship 
between maternal-fetal attachment and maternal health behaviors.  
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Practice  
Social work practitioners could benefit from the findings of this study when 
working with HIV-affected families during pregnancy or after childbirth, in or outside 
health care settings. They could revise their work with HIV-infected mothers based on an 
increased awareness of a potential relationship between the clients’ maternal-fetal 
attachment experience and their health behaviors. In revising their work, practitioners 
may include a developmental dimension to assessing the complex situations reported by 
HIV-infected pregnant women, or intervene from a socio-ecological and strength-based 
perspective which would be complementary or alternative to the medical model typically 
practiced in most health care settings (Bywaters, 1986).  In fact, social work practitioners 
working with these families in any setting may welcome the theoretical framework of this 
study due to its compatibility with the principles of medical social work and infant mental 
health (NASW standards for social work practice in health care settings, 2005; Shonkoff 
& Phillip, 2000). Future research examining the health behaviors of these women from a 
maternal-fetal attachment model may help guide practitioners in designing and delivering 
interventions or programs aiming to protect against poor maternal health behaviors by 
promoting prenatal and postnatal attachments and maternal caregiving (Barbosa & 
Bezerra, 2011).  For example, the women diagnosed with HIV during pregnancy most 
likely lack the knowledge of HIV disease and the experience in coping with this disease, 
in addition to providing this information, they may benefit from working on issues related 
to maternal-fetal attachment, marital relationship, and planned pregnancy status to 
improve their health behaviors during pregnancy.  The maternal sensitivity and reflective 
functioning that equips a mother to effectively read and respond to the cues of her infant 
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could be extended downward to the prenatal period by facilitating maternal-fetal 
attachments (Shin, Park, & Kim, 2006; Slade, Sadle, & Mayes, 2005).   
Policy   
The descriptive findings of this study urge social workers and other public health 
professionals to advocate for those policies in the national agenda to fight HIV/AIDS in 
the U.S. that favor an increase in early access to prenatal and follow-up care for the 
mothers and postnatal HIV-related care the infants (The White House Office of National 
AIDS Policy, 2010). This advocacy work should include those policies which remove 
barriers to access family planning and reproductive health services for HIV-infected 
women, such as lack of health care insurance or perceived stigma. Finally, given the 
findings of a predictive relationship between planned pregnancy status and maternal 
health behaviors for pregnancy care, social work advocates should support the aim of  the 
Healthy People national health initiative to reduce all unintended pregnancies in the U.S. 
by 2020 (Mosher et al., 2012). It is worth noticing that from a public health perspective 
the prevention of unintended pregnancy dovetails the prevention of HIV transmission.  
The descriptive findings of this study suggest the need to advocate for those 
policies, such as the Part D legislation in the Ryan White CARE Act, the main HIV law 
in the U.S. which allocates resources addressing the subsistence and socio-ecological 
needs of HIV-infected mothers, the developmental needs of their affected infants, and the 
socio-emotional health of the mother-child relationship.  The collaborations between Part 
D programs and other universal child welfare or maternal child health federal programs 
addressing unstable housing, poverty, unemployment, and substance abuse in minority 
communities should focus in facilitating the improved health and long-term wellbeing 
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among HIV-affected families (Hernandez & Potocky, in press). These findings also 
suggest that social work practitioners must advocate for universal federal or state policies 
that facilitate the provision of stigma-free services for HIV-affected families to prevent 
unintended pregnancies, promote maternal child health or detect early developmental 
delays. Moreover, advocates should work in partnership with the HIV-infected mothers 
to ensure that these preventive programs respond effectively to their unique psychosocial 
needs, and expand their options in availability of service (Saleebey, 2006). For example, 
existing early intervention programs (e.g. Early Steps or Healthy Start) could detect 
socio-emotional developmental delays or attachment problems early in a HIV-affected 
family and deliver, or facilitate access to realistic and reasonable remedies (Malee et al., 
2011).  
In sum, an effective social work advocacy agenda for HIV affected mother and 
infant dyads must include: a) the coordination of resources between federal laws 
governing HIV programs and universal maternal child health, mental health and child 
welfare policies to address the specific needs of HIV-affected families; b) advanced  
outreach efforts to engage HIV-affected families into programs that provide the services 
they need; and c) increased responsiveness of all service programs to the special needs of 
these underserved and under researched families (Hernandez & Potocky, in press; 
Salisbury, 2000; The White House Office of National AIDS Policy, 2010).  
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APPENDICES 
 
Appendix A 
PID# _______                               Maternal Chart Review 
 
Review Date: ________ 
Lab findings:  
HIV Viral load at enrollment: ______    Date______               
 Last HIV Viral load before delivery: ______   Date______  
Viral resistance testing: □ Yes        □ No       □ N/A 
Resistance resolved: □ Yes     □ No 
Pregnancy HIV Medication Adherence Classification: 
□ High adherence= HIV VL ≤ 40-75 
□ Low adherence= HIV VL > 40-75 
  
HIV disease stage during pregnancy: 
□ HIV infection (Class A or B)          □ AIDS (Class C) 
□ Number of years since HIV diagnosis ______ 
 
Prenatal care entry: □ First Trimester (0-13 weeks) 
                                   □ Second Trimester (14-27 weeks) 
                                   □ Third Trimester ( ≥28 weeks) 
Maternal age at delivery: ______ 
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Appendix B 
PID#_______                                Infant Chart Review 
 
Review Date: _________ 
Attendance to infant’s screening clinic visits: 
2-week appointment:  □ Yes       □ No    Date_____ 
4-week appointment:    □ Yes      □ No   Date_____ 
6-week appointment:   □ Yes      □ No   Date_____ 
16-week appointment:   □ Yes     □ No   Date_____                              
Infant Care Adherence Classification: 
□ Poor Adherence=0-2 visits 
□ Good Adherence=3-4 visits 
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Appendix C 
PID#______                      SOCIO-DEMOGRAPHIC SURVEY                
Date of Birth: _______                                                                       Survey Date: 
_________ 
                       MM/DD/YY                                                                                                                                                                                                      MM/DD/YY 
Educational level: □ Less than 9th grade  □ Some high school  □ High School/GED     
                              □ Some college □ Bachelor’s degree or more    
 
Income: □ less than $10,000 per year    □ $10,001-30,000 per year □ More than 30,000 
per year 
 
Race: □ American Indian or Alaska Native   □ Asian   □ Black or African American   
          □ Native Hawaiian or other Pacific Islander   □ White 
Ethnicity:   □ Hispanic or Latino     □ Not Hispanic or Latino   
 *Marital partner status: □Yes   __Married living with partner __Single living with 
partner 
                                       □ No   __Married not living with partner __Single not living with 
partner 
Problems with partner:  □ Yes          □ No  
 
Gestational age: _____ weeks  
*Planned pregnancy: □ Yes actively planning  
                                   □ No   ___Actively preventing   __ Not preventing/not planning  
Number of previous pregnancies: □ None     □ One     □ Two or more 
Number of live births: □ None     □ One    □ Two or more 
*History of drug use: □ Yes                                                                                    □ No 
Smoking: __ Six months before pregnancy   __Year before pregnancy 
Alcohol use: __Six months before pregnancy __Year before pregnancy 
Marijuana use: __ Six months before pregnancy __Year before pregnancy         
Cocaine use: __Six months before pregnancy   __Year before pregnancy           
Ever injected any drug: __                                                                                 
Other: __             
*HIV diagnosis:  □ perinatal transmission     □ before pregnancy     □ during pregnancy 
* Indicates predictor
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Appendix D.  Maternal-Fetal Attachment Scale (MFAS) 
PID# _____                                                                                                                  
Please respond to the following items about yourself and the baby you are expecting. There is no right or wrong 
answers. Your first impression is usually the best reflection of your feelings. Make sure you mark only one answer 
per sentence.  
I THINK OR DO THE 
FOLLOWING: 
DEFINITELY  
NO 
NO DON’T 
KNOW 
YES DEFINITELY  
YES 
1. I talk to my unborn 
baby. 
     
2. I feel all the trouble 
of being pregnant is 
worth it. 
     
3. I enjoy watching my 
tummy jiggle as the 
baby kicks inside. 
     
4. I picture myself 
feeding the baby. 
     
5. I’m really looking 
forward to seeing 
what the baby looks 
like. 
     
6. I wonder if the baby 
feels cramped in 
there. 
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7. I refer to my baby 
by a nickname. 
 
     
8. I imagine myself 
taking care of the 
baby. 
     
9. I can almost guess 
what my baby’s 
personality will be 
from the way she/he 
moves around. 
     
10. I have decided on 
a name for a baby girl. 
     
11. I do things to try to 
stay healthy that I 
would not do if I were 
not pregnant. 
     
12. I wonder if the 
baby can hear inside 
me. 
     
13. I have decided on 
a name for a baby 
boy. 
     
14. I wonder if the 
baby thinks and feels 
“things” inside of me. 
     
15. I eat meat and 
vegetables to be sure 
my baby gets a good 
diet. 
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16. It seems my baby 
kicks and moves to tell 
me it time to eat. 
     
17. I poke my baby to 
get him/her to poke 
back. 
     
18. I can hardly wait to 
hold my baby. 
     
19. I try to picture 
what the baby will 
look like. 
     
20. I stroke my tummy 
to quiet the baby 
when there is too 
much kicking. 
     
21. I can tell when the 
baby has hiccups. 
     
22. I feel my body is 
ugly. 
     
23. I give up doing 
certain things because 
I want to help my 
baby. 
     
24. I grasp my baby’s 
foot through my 
tummy to move it 
around. 
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Appendix E. PID#_____                   Health Practices Questionnaire 
Circle the one answer that best describes your actions since you found out you were pregnant.  I know that sometimes 
you are prevented from doing things the way you planned because of, for example, illness, nausea, or medical 
necessity.  If these special circumstances apply to you, answer questions by thinking about what you did before the 
problem occurred that required you to change your actions. 
 
1. Since becoming pregnant, I think I am practicing a healthy  
      lifestyle: 
 
2. Since becoming pregnant, I have gotten at least 7 to 8  total hours 
of sleep a night: 
 
3. Since becoming pregnant, I drink more than 2 caffeinated  
      beverages (coffee, tea, colas, or soda in a day: 
 
4.   Since becoming pregnant, I have used marijuana: 
 
5.   Since becoming pregnant, I have used cocaine, crack  
      cocaine, amphetamines or speed, LSD, heroin, or inhalants: 
 
6.  Since becoming pregnant, my partner and/or I have had sex  
     with other people: 
 
7.  Since becoming pregnant, I take actions that reduce my  
     risk for getting sexually transmitted diseases (for example,      
     I have used condoms or avoided intercourse): 
 
8.   When I have questions about my pregnancy or there is  
      something I don’t understand I ask my doctor or midwife: 
 
9.  Since becoming pregnant, I have read food labels to be   
     sure I am buying an item that will be good for me and my  
     baby (for example, not too high in salt or fat, avoiding  
     artificial sweeteners, and good sources of vitamins):                              
 
never rarely sometimes often always 
 
 
never rarely sometimes often always 
 
 
never rarely sometimes often always 
 
never rarely sometimes often always 
 
 
never rarely sometimes often always 
 
 
never rarely sometimes often always 
 
 
 
never rarely sometimes often always 
 
 
never       rarely        sometimes         often        always      
       
 
 
 
never       rarely         sometimes        often        always 
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10. Since becoming pregnant, I have limited or avoided  
      exposure to toxic chemicals and other substances (for   
      example, second-hand smoke, insecticides / pesticides,   
      lead in drinking water): 
 
 
11. Since becoming pregnant, I have taken my multivitamins  
      or prenatal vitamins (if recommended by your doctor or  
      midwife):                                                                                              
 
 
 
 
 
 
12. Since becoming pregnant, I have smoked cigarettes: 
 
 
 
 
 
 
 
 
13. Since becoming pregnant, I have had alcoholic beverages  
      (wine, beer, or liquor): 
 
 
                 
 
 
 
 
 
 
 
never       rarely        sometimes           often        always  
 
 
 
 
 
never 
1 to 2 times a week  
3 to 4 times a week  
5 to 6 times a week   
daily or not recommended 
 
 
 
 
never smoke  
quit since finding out I was pregnant  
less than 10 cigarettes daily  
11 to 20 cigarettes  daily  
more than a pack a day 
 
 
 
 
no alcoholic drinks while pregnant 
before knowing I was pregnant 
less than 3 times a month 
1 time a week  
more than 1 time a week 
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14. Since becoming pregnant, at one sitting I usually drink (a  
      drink is equal to a 12 ounce bottle of beer, 4 ounces of  
      wine or a shot of liquor): 
  
 
 
 
 
 
15. I began seeing my doctor or midwife for prenatal care: 
 
 
 
 
 
 
 
 
16. Since becoming pregnant, I have: (Missed appointment  
      means forgot to schedule or didn’t show up for an  
      appointment with my doctor or midwife): 
 
 
 
 
17. Since becoming pregnant, I have talked with friends and 
      family member to learn more about pregnancy and  
      childbirth. 
 
 
 
 
 
 
 
 
no drinks while pregnant 
1 drink   
2 drinks  
3 drinks  
more than 3 drinks 
 
 
 
 
to plan a pregnancy before conception  
in the first 3 months of pregnancy 
before 5 months  of pregnancy 
before 7 months of pregnancy 
before 9 months of pregnancy 
 
 
 
 
never missed an appointment  
missed one appointment   
missed 2 to 3 appointments  
missed 4 to 5 appointments  
missed more than 5 appointments 
 
 
never  
less than one time a week  
1 to 2 times a week  
3 to 5 times a week   
more than 5 times a week 
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 18. Since becoming pregnant, I have taken time to do  
      something relaxing for myself: 
 
 
 
 
 
 
 
19. Since becoming pregnant, I have gained the amount of  
      weight recommended by my doctor or midwife for this  
      time in pregnancy: 
 
 
 
 
20. I have attended or plan to attend childbirth classes                             
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
K. J. Lindgren, 2002 
University of Wisconsin, School of Nursing, CSC K6/258, 
600 Highland Ave., Madison, WI 53792-2455 
 
never  
less than or one time a month   
2 to 3 times a month   
4 times a month (weekly)    
more than 4 times a month     
 
 
 
 
I have lost weight    
I have gained too little or too much weight  
I have not gained or lost weight  
I do not know 
I have gained the right amount of weight 
 
 
definitely yes 
no, I have taken them before 
not sure 
probably not 
definitely not 
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